US20070156230A1 - Stents with radiopaque markers - Google Patents
Stents with radiopaque markers Download PDFInfo
- Publication number
- US20070156230A1 US20070156230A1 US11/325,973 US32597306A US2007156230A1 US 20070156230 A1 US20070156230 A1 US 20070156230A1 US 32597306 A US32597306 A US 32597306A US 2007156230 A1 US2007156230 A1 US 2007156230A1
- Authority
- US
- United States
- Prior art keywords
- stent
- marker
- depot
- disposed
- deformed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91566—Adjacent bands being connected to each other connected trough to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0029—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
Definitions
- This invention relates to implantable medical devices, such as stents.
- the invention relates to polymeric stents with radiopaque markers.
- This invention relates to radially expandable endoprostheses, which are adapted to be implanted in a bodily lumen.
- An “endoprosthesis” corresponds to an artificial device that is placed inside the body.
- a “lumen” refers to a cavity of a tubular organ such as a blood vessel.
- a stent is an example of such an endoprosthesis.
- Stents are generally cylindrically shaped devices, which function to hold open and sometimes expand a segment of a blood vessel or other anatomical lumen such as urinary tracts and bile ducts. Stents are often used in the treatment of atherosclerotic stenosis in blood vessels.
- Step refers to a narrowing or constriction of the diameter of a bodily passage or orifice.
- stents reinforce body vessels and prevent restenosis following angioplasty in the vascular system.
- Restenosis refers to the reoccurrence of stenosis in a blood vessel or heart valve after it has been treated (as by balloon angioplasty, stenting, or valvuloplasty) with apparent success.
- the structure of stents is typically composed of scaffolding that includes a pattern or network of interconnecting structural elements or struts.
- the scaffolding can be formed from wires, tubes, or sheets of material rolled into a cylindrical shape.
- a medicated stent may be fabricated by coating the surface of either a metallic or polymeric scaffolding with a polymeric carrier.
- the polymeric scaffolding may also serve as a carrier of an active agent or drug.
- the first step in treatment of a diseased site with a stent is locating a region that may require treatment such as a suspected lesion in a vessel, typically by obtaining an x-ray image of the vessel.
- a contrast agent which contains a radiopaque substance such as iodine is injected into a vessel.
- Radiopaque refers to the ability of a substance to absorb x-rays.
- the x-ray image depicts the lumen of the vessel from which a physician can identify a potential treatment region.
- the treatment then involves both delivery and deployment of the stent.
- Delivery refers to introducing and transporting the stent through a bodily lumen to a region in a vessel that requires treatment.
- “Deployment” corresponds to the expanding of the stent within the lumen at the treatment region. Delivery and deployment of a stent are accomplished by positioning the stent about one end of a catheter, inserting the end of the catheter through the skin into a bodily lumen, advancing the catheter in the bodily lumen to a desired treatment location, expanding the stent at the treatment location, and removing the catheter from the lumen.
- the stent is mounted about a balloon disposed on the catheter. Mounting the stent typically involves compressing or crimping the stent onto the balloon. The stent is then expanded by inflating the balloon. The balloon may then be deflated and the catheter withdrawn.
- the stent may be secured to the catheter via a retractable sheath or a sock.
- the sheath may be withdrawn allowing the stent to self-expand.
- the stent must be able to simultaneously satisfy a number of mechanical requirements.
- the stent must be capable of withstanding the structural loads, namely radial compressive forces, imposed on the stent as it supports the walls of a vessel lumen.
- the stent should be longitudinally flexible to allow it to be maneuvered through a tortuous vascular path and to enable it to conform to a deployment site that may not be linear or may be subject to flexure.
- the material from which the stent is constructed must allow the stent to undergo expansion, which typically requires substantial deformation of localized portions of the stent's structure.
- the stent Once expanded, the stent must maintain its size and shape throughout its service life despite the various forces that may come to bear thereon, including the cyclic loading induced by the beating heart. Finally, the stent must be biocompatible so as not to trigger any adverse vascular responses.
- a stent In addition to meeting the mechanical requirements described above, it is desirable for a stent to be radiopaque, or fluoroscopically visible under x-rays. Accurate stent placement is facilitated by real time visualization of the delivery of a stent. A cardiologist or interventional radiologist can track the delivery catheter through the patient's vasculature and precisely place the stent at the site of a lesion. This is typically accomplished by fluoroscopy or similar x-ray visualization procedures. For a stent to be fluoroscopically visible it must be more absorptive of x-rays than the surrounding tissue. Radiopaque materials in a stent may allow for its direct visualization.
- stents fabricated from biodegradable, bioabsorbable, and/or bioerodable materials may be configured to meet this additional clinical requirement since they may be designed to completely erode after the clinical need for them has ended.
- Stents fabricated from biodegradable polymers are particularly promising, in part because they may be designed to completely erode within a desired time frame.
- biodegradable polymers and polymers generally composed of carbon, hydrogen, oxygen, and nitrogen
- they are radiolucent with no radiopacity.
- Biodegradable polymers tend to have x-ray absorption similar to body tissue.
- radiopaque markers can be disposed within a structural element in such a way that the marker is secured to the structural element.
- a radiopaque marker can be disposed within a structural element in such a way that the marker is secured to the structural element.
- the use of stent markers on polymeric stents entails a number of challenges. One challenge relates to the difficulty of insertion of markers.
- Another challenge pertains to the fact that some regions of polymeric struts tend to undergo significant deformation or strain during crimping and expansion. In particular, such changes are due to plastic deformation of polymers. Thus, during stent deployment, the portion of a stent containing an element may crack or stretch as stress is being applied to the expanding stent. As a result, the marker may become dislodged.
- Embodiments of the present invention are directed to a stent including a deformed radiopaque marker disposed in a depot in a portion of the stent.
- the marker may be coupled to the portion at least partially by an interference fit between an expanded portion of the marker and an internal surface of the portion of the stent within the depot.
- at least some gaps between the deformed marker and the internal surface may be filled with a polymeric coating material.
- the markers may include sufficient radiopacity to be imaged by an imaging technique.
- FIG. 1 For embodiments of the present invention, are directed to a method of fabricating a stent that may include disposing a radiopaque marker in a depot in a portion of the stent and compressing the marker to couple the marker within the depot.
- compressing the marker may expand a portion of the marker within the depot to create an interference fit between the expanded portion and an internal surface of the stent within the depot.
- the method may further include applying a coating material to fill gaps between the deformed marker and the internal surface.
- a stent including a radiopaque marker disposed in a depot in a portion of the stent such that the marker may be coupled to the stent at least partially by an interference fit between the marker and a deformed portion of the stent adjacent to the depot.
- Additional embodiments of the present invention are directed to a stent including a radiopaque marker disposed in a depot in a portion of the stent that is configured to accommodate the marker such that a surface of the portion adjacent to the depot may include a recess.
- the recess may facilitate deformation of the portion when the marker is disposed within the depot so as to facilitate coupling of the marker to the portion.
- Additional embodiments of the present invention are directed to a stent including a marker disposed within a depot in a portion of the stent such that the stent may have regions with a lower strain than other higher strain portions when the stent is placed under an applied stress during use.
- the depot may be selectively positioned in a selected region of lower strain.
- FIG. 1 depicts a three-dimensional view of a cylindrically-shaped stent.
- FIG. 2 depicts one embodiment of a stent pattern with a depot for receiving a marker.
- FIG. 3 depicts view of a stent pattern with a marker depot.
- FIGS. 4 A-B depict an overhead and side view of the portion of the stent from FIG. 3 with the marker depot.
- FIG. 5 depicts a cylindrical marker and a portion of a stent with a marker depot.
- FIG. 6 depicts a spherical marker and a portion of a stent with a marker depot.
- FIG. 7 depicts a spherical marker disposed within a depot in a stent.
- FIG. 8A depicts a side view of an uncompressed spherical marker in a depot.
- FIG. 8B depicts a side view of a compressed spherical marker in a depot.
- FIG. 9A depicts a portion of a stent with a depot including ridges.
- FIG. 9B depicts a spherical marker disposed within the depot of FIG. 9A .
- FIG. 10A depicts a portion of a stent with a depot having a non-circular cross-section.
- FIG. 10B depicts a portion of a stent with a spherical marker disposed within the depot in FIG. 10A .
- FIGS. 11 A-B depict an overhead and side view of a portion of a stent with relief cuts adjacent to a marker depot.
- FIG. 12A depicts a portion of a stent with marker depots in a low strain region of a stent.
- FIG. 12B depicts a portion of a stent with markers disposed in the depots of FIG. 12A .
- FIG. 13 depicts an overhead view of the portion of the stent in FIG. 12B .
- the present invention may be applied to stents and, more generally, implantable medical devices such as, but is not limited to, self-expandable stents, balloon-expandable stents, stent-grafts, vascular grafts, cerebrospinal fluid shunts, pacemaker leads, closure devices for patent foramen ovale, and synthetic heart valves.
- implantable medical devices such as, but is not limited to, self-expandable stents, balloon-expandable stents, stent-grafts, vascular grafts, cerebrospinal fluid shunts, pacemaker leads, closure devices for patent foramen ovale, and synthetic heart valves.
- a stent can have virtually any structural pattern that is compatible with a bodily lumen in which it is implanted.
- a stent is composed of a pattern or network of circumferential and longitudinally extending interconnecting structural elements or struts.
- the struts are arranged in patterns, which are designed to contact the lumen walls of a vessel and to maintain vascular patency.
- a myriad of strut patterns are known in the art for achieving particular design goals.
- a few of the more important design characteristics of stents are radial or hoop strength, expansion ratio or coverage area, and longitudinal flexibility.
- the present invention is applicable to virtually any stent design and is, therefore, not limited to any particular stent design or pattern.
- One embodiment of a stent pattern may include cylindrical rings composed of struts. The cylindrical rings may be connected by connecting struts.
- a stent of the present invention may be formed from a tube by laser cutting the pattern of struts in the tube.
- the stent may also be formed by laser cutting a polymeric sheet, rolling the pattern into the shape of the cylindrical stent, and providing a longitudinal weld to form the stent.
- Other methods of forming stents are well known and include chemically etching a polymeric sheet and rolling and then welding it to form the stent.
- a polymeric wire may also be coiled to form the stent.
- the stent may be formed by injection molding of a thermoplastic or reaction injection molding of a thermoset polymeric material. Filaments of the compounded polymer may be extruded or melt spun.
- filaments can then be cut, formed into ring elements, welded closed, corrugated to form crowns, and then the crowns welded together by heat or solvent to form the stent.
- hoops or rings may be cut from tubing stock, the tube elements stamped to form crowns, and the crowns connected by welding or laser fusion to form the stent.
- FIG. 1 depicts a three-dimensional view of a cylindrically-shaped stent 10 with struts 4 that form cylindrical rings 12 which are connected by linking struts 8 .
- the cross-section of the struts in stent 10 is rectangular-shaped.
- the struts have abluminal faces 20 , luminal faces 22 , and sidewall faces 26 .
- the cross-section of struts is not limited to what has been illustrated, and therefore, other cross-sectional shapes are applicable with embodiments of the present invention.
- the pattern should not be limited to what has been illustrated as other stent patterns are easily applicable with embodiments of the present invention.
- a stent can be made of a biostable and/or biodegradable polymer.
- a stent made from a biodegradable polymer is intended to remain in the body for a duration of time until its intended function of, for example, maintaining vascular patency and/or drug delivery is accomplished. After the process of degradation, erosion, absorption, and/or resorption has been completed, no portion of the biodegradable stent, or a biodegradable portion of the stent will remain. In some embodiments, very negligible traces or residue may be left behind.
- the duration can be in a range from about a month to a few years. However, the duration is typically in a range from about one month to twelve months, or in some embodiments, six to twelve months.
- the stent It is important for the stent to provide mechanical support to a vessel for at least a portion of the duration.
- Many biodegradable polymers have erosion rates that make them suitable for treatments that require the presence of a device in a vessel for the above-mentioned time-frames.
- polymers can be biostable, bioabsorbable, biodegradable, or bioerodable.
- Biostable refers to polymers that are not biodegradable.
- biodegradable, bioabsorbable, and bioerodable, as well as degraded, eroded, and absorbed are used interchangeably and refer to polymers that are capable of being completely eroded or absorbed when exposed to bodily fluids such as blood and can be gradually resorbed, absorbed and/or eliminated by the body.
- Biodegradation refers generally to changes in physical and chemical properties that occur in a polymer upon exposure to bodily fluids as in a vascular environment.
- the changes in properties may include a decrease in molecular weight, deterioration of mechanical properties, and decrease in mass due to erosion or absorption.
- Mechanical properties may correspond to strength and modulus of the polymer. Deterioration of the mechanical properties of the polymer decreases the ability of a stent, for example, to provide mechanical support in a vessel.
- the decrease in molecular weight may be caused by, for example, hydrolysis, oxidation, enzymolysis, and/or metabolic processes.
- PEO/PLA polyphosphazenes
- biomolecules such as fibrin, fibrinogen, cellulose, starch, collagen, and hyaluronic acid
- polyurethanes silicones
- polyesters polyolefins, polyisobutylene and ethylene-alphaolefin copolymers
- acrylic polymers and copolymers vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile-styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides, polyethers,
- polymers that may be especially well suited for use in fabricating embodiments of implantable medical devices disclosed herein include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluoropropene) (e.g., SOLEF 21508, available from Solvay Solexis PVDF, Thorofare, N.J.), polyvinylidene fluoride (otherwise known as KYNAR, available from ATOFINA Chemicals, Philadelphia, Pa.), ethylene-vinyl acetate copolymers, poly(vinyl acetate), styrene-isobutylene-styrene triblock copolymers, and polyethylene glycol.
- EVAL ethylene vinyl alcohol copolymer
- poly(butyl methacrylate) poly(vinylidene fluoride-co-hexafluoropropene)
- a stent or marker It is generally desirable to minimize the interference of a stent or marker with the structure of a lumen and/or with flow of bodily fluid through the lumen. Sharp edges, protrusions, etc. in the path of blood flow can result in formation of turbulent and stagnant zones which can act as a nidus for thrombosis. A smaller and/or smoother profile of a body portion may be more hemocompatible. Additionally, a smaller and smoother profile presented by a marker has much less likelihood of catching on other parts of the delivery system such as the guidewire or guiding catheter.
- the embodiments of stents with markers discussed herein do not contribute significantly to the form factor, or profile, of the stent in such a way that interferes with the structure of a lumen and/or with flow of bodily fluid through the lumen.
- stents with markers disposed within depots or holes in a stent include stents with markers disposed within depots or holes in a stent.
- the depot may be formed in a structural element by laser machining.
- the depot may extend partially or completely through the portion of the stent.
- an opening of a depot may be on an abluminal or luminal surface and extend partially through the stent or completely through to an opposing surface.
- the markers may be sufficiently radiopaque for imaging the stent.
- embodiments of the stents with markers tend to be biocompatible and do not interfere with treatment.
- FIG. 2 depicts one embodiment of a stent pattern 40 with depots 44 for receiving a marker.
- stent pattern 40 is shown in a flattened condition showing an abluminal or luminal surface so that the pattern can be clearly viewed.
- Stent pattern 40 includes cylindrically aligned structural elements 46 and linking structural elements 48 .
- Depots 44 are located at a region of intersection of six structural elements or a “spider” region.
- FIG. 3 depicts a three-dimensional view of a stent pattern 60 with depots 62 .
- Stent pattern 60 includes cylindrically aligned structural elements 64 and linking structural elements 66 .
- Depots 62 are located in a portion 68 which is a region of intersection of four structural elements. As depicted in FIG. 3 , depots 62 have a cylindrical shape and extend completely through the radial thickness of structural elements in portion 68 .
- FIG. 4A depicts an overhead view of depot 62 in portion 68 from FIG. 3 .
- FIG. 4B is a side view of depot 62 in portion 68 across line A-A in FIG. 4A .
- Depot 62 has a diameter D and extends all the way through portion 68 which has a radial thickness T.
- Portion 68 has a width Ws along line A-A. D may be greater than 60%, 80%, 100%, 110%, 120%, 130%, or 140% of W S .
- a stent may include a deformed radiopaque marker disposed in a depot in a portion of the stent.
- the marker may be coupled to the portion at least partially by an interference fit between an expanded section of the marker and an internal surface of the portion of the stent within the depot.
- a marker in an undeformed state may be disposed in a depot and compressed to couple the marker within the depot. Compressing the marker may expand a portion of the marker within the depot to create the interference fit. After compressing, the deformed marker may have at least one compressed portion in addition to the expanded portion.
- markers of certain shapes there may be difficulties with the insertion of markers of certain shapes in the depots. For, example, it may be necessary to orient or align a cylindrical element for insertion into a cylindrical depot. Cylindrical markers or slugs can be difficult to insert due to rotation of the slug during insertion.
- FIG. 5 depicts an example of a cylindrical marker 70 having a cylindrical axis 72 . Also shown is a portion 74 of a stent with a cylindrical depot 76 having a cylindrical axis 78 . During insertion, cylindrical marker 70 can rotate so that its axis 72 is not in alignment with axis 78 of depot 76 .
- FIG. 6 depicts a spherical marker 80 and a portion 82 of a stent with a cylindrical depot 84 with an axis 86 .
- FIG. 7 depicts the stent pattern of FIG. 3 with a spherical marker 90 disposed within depot 62 .
- the spherical marker may be completely enclosed within the depot. In other embodiments, the marker may partially project beyond a surface of the stent.
- a marker disposed in a depot may be compressed at the portions at the openings of the depot.
- the marker may then expand within the depot to create an interference fit.
- the compressed portion may correspond to compressed ends with an expanded portion between the ends.
- An interference fit may be between the expanded portion of the marker and the internal surface of the depot.
- a spherical marker may be compressed at two ends and expand about an equator.
- the marker may have a size that allows an interference fit within the depot.
- Such an interference fit may be particularly useful for markers composed of materials that are relatively easily deformed or malleable, such as, but not limited to gold.
- a marker may be placed in the depot and then pressed into place with a small flat tool or a machined fixture.
- the marker may be disposed in a depot using a syringe.
- the markers may be held at the end of the syringe by a vacuum or surface tension of a viscous fluid.
- the markers may be heated prior to placement into the depot.
- gaps between the marker and the internal surface of the depot may allow a marker to become loose and fall out of the depot.
- at least some of the gaps between the deformed marker and the internal surface may be filled with a polymeric coating.
- a coating material composed of a polymer dissolved in a solvent may be applied to fill the gaps.
- the coating material may be applied in various ways known in the art such as by spraying or dipping.
- FIG. 8A depicts a side view, as in FIG. 4B , across a portion 104 of a stent with a depot 102 with a spherical marker 100 disposed within depot 102 .
- FIG. 8B illustrates an interference fit between marker 100 and portion 104 .
- Marker 100 is compressed at ends 106 and 108 which causes expansion around an equator 112 .
- a void 109 may be filled with a polymeric coating material, as described above.
- Some materials that are desirable for use in markers such as platinum may be difficult to compress and deform to create an interference fit. Compressing such materials may cause damage to portions of a stent adjacent to a depot. Therefore, it may be desirable to couple a marker within a depot in an undeformed or substantially undeformed state through deformation of the stent adjacent to the depot.
- a stent may include a radiopaque marker disposed in a depot in a portion of the stent.
- the marker may be coupled to the stent at least partially by an interference fit between the marker and a deformed portion of the stent adjacent to the depot.
- the marker may be undeformed or substantially undeformed after being coupled to the stent.
- the deformed portion of the stent within the depot may include deformable projections adapted to deform when the marker is disposed in the depot.
- the projections may include ridges that are parallel, perpendicular, or between parallel and perpendicular to a cylindrical axis of the depot.
- FIG. 9A depicts a portion of a stent pattern with a depot 120 in a spider region 122 .
- Depot 120 has ridges 124 .
- FIG. 9B depicts a spherical marker 128 disposed within depot 120 of FIG. 9A .
- Marker 128 is coupled by an interference fit between undeformed marker 128 and deformed ridges 124 .
- Voids 130 are shown between ridges 124 .
- coupling of the marker within a depot may be facilitated by at least partially filling the void with polymeric coating material, as described above.
- a depot may have a cross-section different from a cross-section of the marker.
- a length across a portion of the depot may be less than a cross-section of a marker.
- the portion of the stent may deform to change the cross-section of the depot to accommodate the marker.
- the deformation of the stent may create an interference fit between the marker and a portion of the surface of the stent within the depot.
- depots with non-circular cross-sections can be a variety of shapes such as oval, ellipsoid, rectangular, etc.
- FIG. 10A depicts an overhead view of a portion 140 of a stent with a depot 144 having a non-circular cross-section.
- Depot 144 has a width, W O , that is less than a diameter D S of a spherical marker.
- FIG. 10B depicts portion 140 with a spherical marker 146 with diameter D S disposed within depot 144 from FIG. 10A .
- Portion 140 deforms to accommodate marker 146 to create an interference fit between marker 146 and a portion of the surface of portion 140 within depot 144 .
- Voids 148 may be filled with a polymeric coating material, as described above.
- a marker within a depot may cause deformation in a portion of the stent adjacent to the depot. It may be desirable to increase the flexibility of the portion to reduce or eliminate damage to the stent as the portion deforms.
- a surface of the portion adjacent to the depot may include a recess. The recess may facilitate deformation or increase the flexibility of the portion when the marker is disposed within the depot so as to facilitate coupling of the marker to the portion.
- the recess may be a groove in communication with the depot.
- the surface may include more than one groove of various widths and depths.
- a groove may have a width that is less than 1%, 3%, 5%, 10%, 15%, 20%, or 20% of a diameter of a depot.
- a groove may have a depth that is less than 1%, 3%, 5%, 10%, 15%, or 20% of a radial thickness of a strut that has the depot.
- FIG. 11A depicts an overhead view of a portion 150 of a stent with a depot 154 for a marker. Portion 150 has grooves 158 in communication with the depot.
- FIG. 11B depicts a side view of grooves 158 facing an internal surface 164 of depot 154 . Grooves 158 have depth D G and a width W G . Grooves 158 are depicted with a rectangular cross-section, however, a groove may also have a rounded cross-section.
- regions of polymeric struts tend to undergo significant deformation or strain during crimping and expansion.
- regions include curved or bent regions such as regions 14 , 16 , and 18 in FIG. 1 as well as regions where structural elements intersect such as portion 68 in FIG. 3 .
- the material surrounding a depot located in such regions may crack or stretch as stress is being applied to the expanding stent, and the marker may become dislodged.
- Straight or relatively straight portions such as section 19 in FIG. 1 tend to experience relatively low strain even during crimping and expansion.
- the higher mass or thickness may reinforce the region which can at least partially compensate for the presence of the depot.
- a region can be reinforced with added mass of stent material so that it can adequately withstand the stress of crimping and expansion without significant distortion of the structural element in the region of the depot.
- a high strain region tends to require a larger mass to compensate for the depot than a low strain region.
- An increase in mass of a stent increases the form factor of the stent, which is generally not desirable.
- a stent may include a marker disposed within a depot in a portion of the stent.
- the stent may have regions with a lower strain than other higher strain regions when the stent is placed under an applied stress during use.
- the depot may be selectively positioned in a selected region of lower strain.
- the selected region of the structural element may be modified to have a higher mass or thickness than a region of lower strain without a marker so as to maintain the load-bearing capability of the selected region and to inhibit decoupling of the marker from the stent.
- FIG. 12A depicts a stent pattern 180 with depots 182 in portion 184 , a low strain region of a stent.
- portion 184 is wider than a structural element 186 that has no depots.
- Portion 184 is wider or has more mass to maintain the structural integrity of the stent.
- FIG. 12B depicts spherical markers 188 disposed within depots 182 .
- FIGS. 12 A-B one of the advantages of disposing markers in low strain regions such as portion 184 is that multiple markers can be accommodated. Thus, the visibility of the stent in enhanced.
- FIG. 13 depicts an overhead view of portion 184 from FIGS. 12 A-B.
- the part of portion 184 that is not reinforced has a width W L and a width of the reinforced part is W R .
- W R may be greater than 120%, 140%, 160%, 180%, 200%, 220%, or 250% of W L .
- a spherical marker may additionally or alternatively be coupled within a depot with any suitable biocompatible adhesive.
- the adhesive may include a solvent.
- the solvent may dissolve the polymer of the structural element within the depot to allow the marker within the depot to be coupled to the structural element.
- a solvent may also dissolve a portion of the marker.
- the adhesive may include a solvent mixed with a polymer. The solvent or the solvent-polymer mixture may be applied to the structural element within the depot or the marker followed by disposing the marker within the depot. The solvent may then be removed through evaporation. Evaporation may be facilitated by, for example, heating the structural element in an oven or by some other method.
- solvents may include, but are not limited to, chloroform, acetone, chlorobenzene, ethyl acetate, 1,4-dioxane, ethylene dichloride, 2-ethyhexanol, and combinations thereof.
- Representative polymers may include biostable and biodegradable polymers disclosed herein that may be dissolved by the selected solvent.
- adhesives may include, but are not limited to, thermosets such as, for example, epoxies, polyesters and phenolics; thermoplastics such as, for example, polyamides, polyesters and ethyl vinyl acetate (EVA) copolymers; and elastomers such as, for example, natural rubber, styrene-isoprene-styrene block copolymers, and polyisobutylene.
- Other adhesives include, but are not limited to, proteins; cellulose; starch; poly(ethylene glycol); fibrin glue; and derivatives and combinations thereof.
- mixtures of solvents and another substance can be used to form adhesives.
- mixtures of water and sugar such as, for example, mixtures of water and sucrose
- mixtures of PEG, or derivatives thereof can be mixed with a suitable solvent to form an adhesive.
- suitable solvents for PEG, or derivatives thereof include, but are not limited to, water, ethanol, chloroform, acetone, and the like.
- the marker can be coupled to the structural element by a thermal weld.
- a metallic marker Prior to disposing the marker in the structural element, a metallic marker may be heated to a temperature that can melt at least a portion of the polymer of the structural element.
- a marker including a polymer can be heated to a temperature at or above its melting temperature prior to disposing the marker in the depot.
- the markers may be coupled to any desired location on a stent.
- markers can be placed only at the distal and proximal ends of the stent.
- a device such as a stent may typically include two or more markers coupled to various locations of the stent.
- the markers may be distributed in a manner that facilitates visualization of the stent during and after implantation. For instance, the markers may be distributed circumferentially and longitudinally throughout a stent pattern.
- a stent may include a biostable and/or a biodegradable polymer.
- the biodegradable polymer may be a pure or substantially pure biodegradable polymer.
- the biodegradable polymer may be a mixture of at least two types of biodegradable polymers.
- the stent may be configured to completely erode away once its function is fulfilled.
- the marker may be biodegradable. It may be desirable for the marker to degrade at the same or substantially the same rate as the stent. For instance, the marker may be configured to completely or almost completely erode at the same time or approximately the same time as the stent. In other embodiments, the marker may degrade at a faster rate than the stent. In this case, the marker may completely or almost completely erode before the body of the stent is completely eroded.
- a radiopaque marker may be composed of a biodegradable and/or biostable metal.
- Biodegradable or bioerodable metals tend to erode or corrode relatively rapidly when exposed to bodily fluids.
- Biostable metals refer to metals that are not biodegradable or bioerodable or have negligible erosion or corrosion rates when exposed to bodily fluids.
- metal erosion or corrosion involves a chemical reaction between a metal surface and its environment. Erosion or corrosion in a wet environment, such as a vascular environment, results in removal of metal atoms from the metal surface. The metal atoms at the surface lose electrons and become charged ions that leave the metal to form salts in solution.
- a biocompatible biodegradable metal forms erosion products that do not negatively impact bodily functions.
- the radiopaque marker may be composed of a pure or substantially pure biodegradable metal.
- the marker may be a mixture or alloy of at least two types of metals.
- biodegradable metals for use in a marker may include, but are not limited to, magnesium, zinc, and iron.
- Representative mixtures or alloys may include magnesium/zinc, magnesium/iron, zinc/iron, and magnesium/zinc/iron.
- Radiopaque compounds such as iodine salts, bismuth salts, or barium salts may be compounded into the metallic biodegradable marker to further enhance the radiopacity.
- biostable metals can include, but are not limited to, platinum and gold.
- the composition of the marker may be modified or tuned to obtain a desired erosion rate and/or degree of radiopacity.
- the erosion rate of the marker may be increased by increasing the fraction of a faster eroding component in an alloy.
- the degree of radiopacity may be increased by increasing the fraction of a more radiopaque metal, such as iron, in an alloy.
- a biodegradable marker may be completely eroded when exposed to bodily fluids, such as blood, between about a week and about three months, or more narrowly, between about one month and about two months.
- a radiopaque marker may be a mixture of a biodegradable polymer and a radiopaque material.
- a radiopaque material may be biodegradable and/or bioabsorbable.
- Representative radiopaque materials may include, but are not limited to, biodegradable metallic particles and particles of biodegradable metallic compounds such as biodegradable metallic oxides, biocompatible metallic salts, gadolinium salts, and iodinated contrast agents.
- the radiopacity of the marker may be increased by increasing the composition of the radiopaque material in the marker.
- the radiopaque material may be between 10% and 80%; 20% and 70%; 30% and 60%; or 40% and 50% by volume of the marker.
- the biodegradable polymer in the marker may be a pure or substantially pure biodegradable polymer.
- the biodegradable polymer may be a mixture of at least two types of biodegradable polymers.
- the composition of the biodegradable polymer may be modified to alter the erosion rate of the marker since different biodegradable polymers have different erosion rates.
- a biocompatible metallic salt refers to a salt that may be safely absorbed by a body.
- Representative biocompatible metallic salts that may used in a marker include, but are not limited to, ferrous sulfate, ferrous gluconate, ferrous carbonate, ferrous chloride, ferrous fumarate, ferrous iodide, ferrous lactate, ferrous succinate, barium sulfate, bismuth subcarbonate, bismuth potassium tartrate, bismuth sodium iodide, bismuth sodium tartrate, bismuth sodium triglycollamate, bismuth subsalicylate, zinc acetate, zinc carbonate, zinc citrate, zinc iodate, zinc iodide, zinc lactate, zinc phosphate, zinc salicylate, zinc stearate, zinc sulfate, and combinations thereof.
- the concentration of the metallic salt in the marker may be between 10% and 80%; 20% and 70%; 30% and 60%; or 40% and 50% by volume of the marker.
- representative iodinated contrast agents may include, but are not limited to acetriozate, diatriozate, iodimide, ioglicate, iothalamate, ioxithalamate, selectan, uroselectan, diodone, metrizoate, metrizamide, iohexol, ioxaglate, iodixanol, lipidial, ethiodol, and combinations thereof.
- concentration of an iodinated contrast agent in the marker may be between 5% and 80%; 20% and 70%; 30% and 60%; or 40% and 50% by volume of the marker.
- the composition of metallic particles may include at least those biodegradable metals discussed above as well as metallic compounds such as oxides.
- concentration of metallic particles in the marker may be between 10% and 80%; 20% and 70%; 30% and 60%; or 40% and 50% by volume of the marker.
- individual metallic particles may be a pure or substantially pure metal or a metal compound.
- individual metallic particles may be a mixture of at least two types of metals or metallic compounds.
- Individual metallic particles may also be a mixture or an alloy composed of at least two types of metals.
- the metallic particles may be metallic nanoparticles.
- a “nanoparticle” refers to a particle with a dimension in the range of about 1 nm to about 100 nm.
- a significant advantage of nanoparticles over larger particles is that nanoparticles may disperse more uniformly in a polymeric matrix, which results in more uniform properties such as radiopacity and erosion rate. Additionally, nanoparticles may be more easily absorbed by bodily fluids such as blood without negative impact to bodily functions.
- Representative examples of metallic particles may include, but are not limited to, iron, magnesium, zinc, platinum, gold, and oxides of such metals.
- composition of different types of metallic particles in the mixture as well as the composition of individual particles may be modified to alter erosion rates and/or radiopacity of the marker.
- the ratio of polymer to metallic particles may be modified to alter both the erosion rate and radiopacity.
- a marker may be fabricated by methods including, but not limited to, molding, machining, assembly, or a combination thereof. All or part of a metallic or polymeric marker may be fabricated in a mold or machined by a method such as laser machining.
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/325,973 US20070156230A1 (en) | 2006-01-04 | 2006-01-04 | Stents with radiopaque markers |
JP2008549504A JP5175220B2 (ja) | 2006-01-04 | 2006-12-21 | 放射線不透過性マーカ付きステント |
ES06848153.0T ES2458191T3 (es) | 2006-01-04 | 2006-12-21 | Stents con marcadores radiopacos |
PT68481530T PT1973502E (pt) | 2006-01-04 | 2006-12-21 | Stents com marcadores radiopacos |
DK06848153.0T DK1973502T3 (da) | 2006-01-04 | 2006-12-21 | Stenter med strålings-transparente markører |
SI200731807A SI2910220T1 (sl) | 2006-01-04 | 2006-12-21 | Žilne opornice z markerji za rentgenske žarke |
EP06848153.0A EP1973502B1 (de) | 2006-01-04 | 2006-12-21 | Stents mit röntgenopaken markierungen |
PL06848153T PL1973502T3 (pl) | 2006-01-04 | 2006-12-21 | Stenty z radiocieniującymi znacznikami |
HUE14200352A HUE029840T2 (en) | 2006-01-04 | 2006-12-21 | Stents with radiopak markers |
EP16177926.9A EP3146941B1 (de) | 2006-01-04 | 2006-12-21 | Stents mit röntgenundurchlässigen markern |
EP13161281.4A EP2612620A3 (de) | 2006-01-04 | 2006-12-21 | Stents mit röntgendichten Markern |
DK14200352.4T DK2910220T3 (en) | 2006-01-04 | 2006-12-21 | STENTS WITH X-ray-absorbing markers |
ES14200352.4T ES2586978T3 (es) | 2006-01-04 | 2006-12-21 | Endoprótesis vasculares con marcadores radiopacos |
EP14200352.4A EP2910220B1 (de) | 2006-01-04 | 2006-12-21 | Stents mit röntgendichten markern |
PL14200352.4T PL2910220T3 (pl) | 2006-01-04 | 2006-12-21 | Stenty ze znacznikami radiocieniującymi |
PCT/US2006/049269 WO2007081551A1 (en) | 2006-01-04 | 2006-12-21 | Stents with radiopaque markers |
LTEP14200352.4T LT2910220T (lt) | 2006-01-04 | 2006-12-21 | Stentai su rentgenokontrastiniais markeriais |
PT142003524T PT2910220T (pt) | 2006-01-04 | 2006-12-21 | Stents com marcadores radiopacos |
SI200631774T SI1973502T1 (sl) | 2006-01-04 | 2006-12-21 | Stenti z radioneprepustnimi označevalci |
CY20141100429T CY1115184T1 (el) | 2006-01-04 | 2014-06-11 | Ενδοπροθεσεις με ακτινοσκιερους δεικτες |
US14/588,286 US9532888B2 (en) | 2006-01-04 | 2014-12-31 | Stents with radiopaque markers |
HK16101845.7A HK1213761A1 (zh) | 2006-01-04 | 2016-02-18 | 具有射線不可穿透的標誌物的支架 |
CY20161101004T CY1118086T1 (el) | 2006-01-04 | 2016-10-10 | Στεντ με ακτινοσκιερους δεικτες |
US15/357,987 US10070975B2 (en) | 2006-01-04 | 2016-11-21 | Stents with radiopaque markers |
US16/126,870 US20190021809A1 (en) | 2006-01-04 | 2018-09-10 | Stents with radiopaque markers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/325,973 US20070156230A1 (en) | 2006-01-04 | 2006-01-04 | Stents with radiopaque markers |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/588,286 Continuation US9532888B2 (en) | 2006-01-04 | 2014-12-31 | Stents with radiopaque markers |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070156230A1 true US20070156230A1 (en) | 2007-07-05 |
Family
ID=38057328
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/325,973 Abandoned US20070156230A1 (en) | 2006-01-04 | 2006-01-04 | Stents with radiopaque markers |
US14/588,286 Active US9532888B2 (en) | 2006-01-04 | 2014-12-31 | Stents with radiopaque markers |
US15/357,987 Active US10070975B2 (en) | 2006-01-04 | 2016-11-21 | Stents with radiopaque markers |
US16/126,870 Abandoned US20190021809A1 (en) | 2006-01-04 | 2018-09-10 | Stents with radiopaque markers |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/588,286 Active US9532888B2 (en) | 2006-01-04 | 2014-12-31 | Stents with radiopaque markers |
US15/357,987 Active US10070975B2 (en) | 2006-01-04 | 2016-11-21 | Stents with radiopaque markers |
US16/126,870 Abandoned US20190021809A1 (en) | 2006-01-04 | 2018-09-10 | Stents with radiopaque markers |
Country Status (13)
Country | Link |
---|---|
US (4) | US20070156230A1 (de) |
EP (4) | EP3146941B1 (de) |
JP (1) | JP5175220B2 (de) |
CY (2) | CY1115184T1 (de) |
DK (2) | DK2910220T3 (de) |
ES (2) | ES2586978T3 (de) |
HK (1) | HK1213761A1 (de) |
HU (1) | HUE029840T2 (de) |
LT (1) | LT2910220T (de) |
PL (2) | PL2910220T3 (de) |
PT (2) | PT1973502E (de) |
SI (2) | SI1973502T1 (de) |
WO (1) | WO2007081551A1 (de) |
Cited By (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060161242A1 (en) * | 2005-01-17 | 2006-07-20 | Lee Kyung B | Multilayer-coated stent for controlled drug release and manufacturing method thereof |
US20070266542A1 (en) * | 2006-05-08 | 2007-11-22 | Cook Incorporated | Radiopaque marker for intraluminal medical device |
US20080243227A1 (en) * | 2007-03-30 | 2008-10-02 | Lorenzo Juan A | Radiopaque markers for implantable stents and methods for manufacturing the same |
US20080288046A1 (en) * | 2007-05-16 | 2008-11-20 | Boston Scientific Scimed, Inc. | Method of Attaching Radiopaque Markers to Intraluminal Medical Devices, and Devices Formed Using the Same |
US20080306581A1 (en) * | 2007-06-07 | 2008-12-11 | Medtronic Vascular, Inc. | Streamlined Stents |
US20090035351A1 (en) * | 2007-07-20 | 2009-02-05 | Medtronic Vascular, Inc. | Bioabsorbable Hypotubes for Intravascular Drug Delivery |
US20090187936A1 (en) * | 2007-12-21 | 2009-07-23 | Jelli, Inc. | Social broadcasting |
US20090204203A1 (en) * | 2008-02-07 | 2009-08-13 | Medtronic Vascular, Inc. | Bioabsorbable Stent Having a Radiopaque Marker |
US20100256744A1 (en) * | 1996-06-06 | 2010-10-07 | Jean-Claude Laborde | Bifurcation stent and method of positioning in a body lumen |
US20110034991A1 (en) * | 2006-08-07 | 2011-02-10 | Biotronik Vi Patent Ag | Endoprosthesis and method for producing same |
WO2011094621A1 (en) | 2010-01-30 | 2011-08-04 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
WO2011140973A1 (zh) * | 2010-05-10 | 2011-11-17 | 上海微特生物技术有限公司 | 一种能使聚合物支架在x射线下清晰可见的显影标记 |
WO2012145106A1 (en) | 2011-04-19 | 2012-10-26 | Abbott Cardiovascular Systems Inc. | Processes for making crush recoverable polymer scaffolds |
WO2013135260A1 (de) * | 2012-03-16 | 2013-09-19 | Admedes Schuessler Gmbh | Körperimplantat mit markerelement |
US8566254B2 (en) * | 2007-12-21 | 2013-10-22 | Jelli, Inc. | Social broadcasting user experience |
US20140013574A1 (en) * | 2012-07-11 | 2014-01-16 | Intact Vascular, Inc. | Systems and methods for attaching radiopaque markers to a medical device |
US20140114434A1 (en) * | 2012-10-22 | 2014-04-24 | Orbusneich Medical, Inc. | Medical device for implantation into luminal structures |
US8752268B2 (en) * | 2006-05-26 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Method of making stents with radiopaque markers |
US20140172112A1 (en) * | 2011-08-16 | 2014-06-19 | Depuy (Ireland) | Attachment mechanism |
EP2752173A1 (de) | 2010-01-30 | 2014-07-09 | Abbott Cardiovascular Systems, Inc. | Gegen Quetschung unempfindliche Polymerstents |
US9078045B2 (en) | 2007-12-21 | 2015-07-07 | Jelli, Inc. | Social broadcasting platform |
US9089422B2 (en) * | 2008-01-24 | 2015-07-28 | Medtronic, Inc. | Markers for prosthetic heart valves |
US20150238335A1 (en) * | 2014-02-26 | 2015-08-27 | Suntech Co., Ltd. | Polymeric stent and methods of manufacturing the same |
US20150272751A1 (en) * | 2012-10-25 | 2015-10-01 | Arterial Remodeling Technologies, Sa | Radiopaque marker for bioresorbable stents |
CN105188617A (zh) * | 2013-05-07 | 2015-12-23 | 株式会社钟化 | 支架、其制造方法及制造装置 |
US9233015B2 (en) | 2012-06-15 | 2016-01-12 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
US20160228267A1 (en) * | 2015-02-11 | 2016-08-11 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
WO2016137843A1 (en) * | 2015-02-24 | 2016-09-01 | Abbott Cardiovascular Systems Inc. | System and method for attaching a radiopaque marker bead to an endoprosthesis |
WO2016201317A1 (en) | 2015-06-12 | 2016-12-15 | Abbott Cardiovascular Systems Inc. | Scaffolds having a radiopaque marker and methods for attaching a marker to a scaffold |
US9532888B2 (en) | 2006-01-04 | 2017-01-03 | Abbott Cardiovascular Systems Inc. | Stents with radiopaque markers |
WO2017066201A1 (en) | 2015-10-16 | 2017-04-20 | Abbott Cardiovascular Systems Inc. | Non-circular radiopaque markers and methods for attaching a marker to a scaffold |
WO2017106557A1 (en) | 2015-12-17 | 2017-06-22 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds |
US9827119B2 (en) | 2010-01-30 | 2017-11-28 | Abbott Cardiovascular Systems Inc. | Polymer scaffolds having a low crossing profile |
US9861507B2 (en) | 2015-12-17 | 2018-01-09 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having modified marker structure near distal end |
US9956099B2 (en) | 2015-12-17 | 2018-05-01 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having reduced crimp profile and carrying radiopaque markers |
US9980835B2 (en) | 2013-10-22 | 2018-05-29 | Orbusneich Medical Inc. | Medical device for implantation into luminal structures incorporating corrugated structural elements |
US10004619B2 (en) | 2012-09-20 | 2018-06-26 | Dotter Intellectual Pte, Ltd. | Polymeric stent and methods of manufacturing the same |
US10143573B2 (en) | 2015-12-17 | 2018-12-04 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having flexible distal end |
US10206796B2 (en) | 2014-08-27 | 2019-02-19 | DePuy Synthes Products, Inc. | Multi-strand implant with enhanced radiopacity |
US10272230B2 (en) | 2015-10-30 | 2019-04-30 | Cerevasc, Llc | Systems and methods for treating hydrocephalus |
US10279154B2 (en) | 2014-10-31 | 2019-05-07 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US10307274B2 (en) | 2011-07-29 | 2019-06-04 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
USD896383S1 (en) | 2018-09-13 | 2020-09-15 | Allergan, Inc. | Tissue expansion device |
US10821008B2 (en) | 2016-08-25 | 2020-11-03 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
US10893963B2 (en) | 2018-08-06 | 2021-01-19 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
US11013900B2 (en) | 2018-03-08 | 2021-05-25 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
US11039944B2 (en) | 2018-12-27 | 2021-06-22 | DePuy Synthes Products, Inc. | Braided stent system with one or more expansion rings |
US11090175B2 (en) | 2018-07-30 | 2021-08-17 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
EP3721839A4 (de) * | 2017-12-06 | 2021-08-18 | Biotyx Medical (Shenzhen) Co., Ltd. | Stütze und herstellungsverfahren dafür |
US11129738B2 (en) | 2016-09-30 | 2021-09-28 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
US11160630B2 (en) | 2018-09-13 | 2021-11-02 | Allergan, Inc. | Tissue expansion device |
US11278708B2 (en) | 2014-01-15 | 2022-03-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US11357648B2 (en) | 2018-08-06 | 2022-06-14 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
US11452623B2 (en) | 2013-03-13 | 2022-09-27 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080009938A1 (en) * | 2006-07-07 | 2008-01-10 | Bin Huang | Stent with a radiopaque marker and method for making the same |
US10022250B2 (en) | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
US7896911B2 (en) | 2007-12-12 | 2011-03-01 | Innovasc Llc | Device and method for tacking plaque to blood vessel wall |
US10166127B2 (en) | 2007-12-12 | 2019-01-01 | Intact Vascular, Inc. | Endoluminal device and method |
JP5243080B2 (ja) * | 2008-03-31 | 2013-07-24 | テルモ株式会社 | 生体内留置用ステントおよび生体器官拡張器具 |
US9168161B2 (en) * | 2009-02-02 | 2015-10-27 | Cordis Corporation | Flexible stent design |
US8945090B2 (en) | 2009-12-29 | 2015-02-03 | Cardiac Pacemakers, Inc. | Implantable radiopaque marking |
US10271973B2 (en) | 2011-06-03 | 2019-04-30 | Intact Vascular, Inc. | Endovascular implant |
DE102012107261B4 (de) * | 2012-08-08 | 2015-11-12 | Acandis Gmbh & Co. Kg | Medizinische Vorrichtung zur Einfuhr in einen lebenden Körper und Verfahren zum Herstellen einer derartigen Vorrichtung |
AU2014207290B2 (en) * | 2013-01-18 | 2018-04-05 | The Johns Hopkins University | Ultrasound-detectable markers, ultrasound system, and methods for monitoring vascular flow and patency |
US10518003B2 (en) | 2014-07-07 | 2019-12-31 | Meril Life Sciences Pvt. Ltd. | Method to manufacture thin strut stent from bioabsorbable polymer with high fatigue and radial strength |
US10675387B2 (en) | 2014-07-07 | 2020-06-09 | Meril Life Sciences Pvt. Ltd. | Multi stage radial deformation for manufacturing thin strut stent from bioabsorbable polymer |
AU2014400542B2 (en) | 2014-07-07 | 2019-05-02 | Meril Life Sciences Pvt. Ltd. | Thin strut stent from bioabsorbable polymer with high fatigue and radial strength and method to manufacture thereof |
US10603833B2 (en) | 2014-07-07 | 2020-03-31 | Meril Life Sciences Pvt. Ltd. | Method to manufacture thin strut stent from bioabsorbable polymer |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
EP3165238B1 (de) | 2015-11-04 | 2018-02-14 | Biotronik AG | Röntgenmarker für eine endoprothese |
US10596660B2 (en) | 2015-12-15 | 2020-03-24 | Howmedica Osteonics Corp. | Porous structures produced by additive layer manufacturing |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
JP2019150077A (ja) * | 2016-07-22 | 2019-09-12 | テルモ株式会社 | ステント |
DE102016114894A1 (de) | 2016-08-11 | 2018-02-15 | Cortronik GmbH | Röntgenmarker für absorbierbare metallische Scaffolds mit hoher Röntgensichtbarkeit und integriertem Selbstpassivierungseffekt |
ES2836190T3 (es) | 2016-08-10 | 2021-06-24 | Cortronik GmbH | Marcador de rayos x para estructura metálica absorbible con alta visibilidad de rayos x y efecto de autopasivación integrado |
CN110650707B (zh) | 2017-05-22 | 2021-11-30 | 波士顿科学国际有限公司 | 装置和利用具有射线不可透细丝的装置的方法 |
US11628517B2 (en) | 2017-06-15 | 2023-04-18 | Howmedica Osteonics Corp. | Porous structures produced by additive layer manufacturing |
DE102017211835A1 (de) * | 2017-07-11 | 2019-01-17 | Bip Biomedizinische Instrumente Und Produkte Gmbh | Medizinischer, implantierbarer Marker und Vorrichtung zum Implantieren des Markers |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
EP3479798B1 (de) | 2017-11-03 | 2023-06-21 | Howmedica Osteonics Corp. | Flexibles konstrukt zur femurrekonstruktion |
WO2020236174A1 (en) * | 2019-05-22 | 2020-11-26 | Q3 Medical Devices Limited | Biodegradable supporting device with a radio-opaque marker |
WO2021192636A1 (ja) * | 2020-03-27 | 2021-09-30 | テルモ株式会社 | 生体内留置用ステントおよびステントデリバリーシステム |
CN113855353B (zh) * | 2020-06-30 | 2023-01-03 | 微创神通医疗科技(上海)有限公司 | 显影结构、支架及取栓系统 |
KR102505005B1 (ko) * | 2020-12-18 | 2023-03-03 | (주)시지바이오 | 스텐트 |
US11147694B1 (en) | 2021-03-26 | 2021-10-19 | Vesper Medical, Inc. | Medical implants with structural members having barbs for retaining radiopaque markers |
EP4257095B1 (de) * | 2022-04-04 | 2024-04-03 | Sanita Biosciences BV | Flexibler stent und herstellungsverfahren dafür |
Citations (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321711A (en) * | 1978-10-18 | 1982-03-30 | Sumitomo Electric Industries, Ltd. | Vascular prosthesis |
US4633873A (en) * | 1984-04-26 | 1987-01-06 | American Cyanamid Company | Surgical repair mesh |
US4656083A (en) * | 1983-08-01 | 1987-04-07 | Washington Research Foundation | Plasma gas discharge treatment for improving the biocompatibility of biomaterials |
US4718907A (en) * | 1985-06-20 | 1988-01-12 | Atrium Medical Corporation | Vascular prosthesis having fluorinated coating with varying F/C ratio |
US4722335A (en) * | 1986-10-20 | 1988-02-02 | Vilasi Joseph A | Expandable endotracheal tube |
US4723549A (en) * | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
US4732152A (en) * | 1984-12-05 | 1988-03-22 | Medinvent S.A. | Device for implantation and a method of implantation in a vessel using such device |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4740207A (en) * | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4816339A (en) * | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US4818559A (en) * | 1985-08-08 | 1989-04-04 | Sumitomo Chemical Company, Limited | Method for producing endosseous implants |
US4902289A (en) * | 1982-04-19 | 1990-02-20 | Massachusetts Institute Of Technology | Multilayer bioreplaceable blood vessel prosthesis |
US4994298A (en) * | 1988-06-07 | 1991-02-19 | Biogold Inc. | Method of making a biocompatible prosthesis |
US5084065A (en) * | 1989-07-10 | 1992-01-28 | Corvita Corporation | Reinforced graft assembly |
US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
US5100429A (en) * | 1989-04-28 | 1992-03-31 | C. R. Bard, Inc. | Endovascular stent and delivery system |
US5104410A (en) * | 1990-10-22 | 1992-04-14 | Intermedics Orthopedics, Inc | Surgical implant having multiple layers of sintered porous coating and method |
US5108417A (en) * | 1990-09-14 | 1992-04-28 | Interface Biomedical Laboratories Corp. | Anti-turbulent, anti-thrombogenic intravascular stent |
US5108755A (en) * | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
US5192311A (en) * | 1988-04-25 | 1993-03-09 | Angeion Corporation | Medical implant and method of making |
US5197977A (en) * | 1984-01-30 | 1993-03-30 | Meadox Medicals, Inc. | Drug delivery collagen-impregnated synthetic vascular graft |
US5279594A (en) * | 1990-05-23 | 1994-01-18 | Jackson Richard R | Intubation devices with local anesthetic effect for medical use |
US5282860A (en) * | 1991-10-16 | 1994-02-01 | Olympus Optical Co., Ltd. | Stent tube for medical use |
US5289831A (en) * | 1989-03-09 | 1994-03-01 | Vance Products Incorporated | Surface-treated stent, catheter, cannula, and the like |
US5290271A (en) * | 1990-05-14 | 1994-03-01 | Jernberg Gary R | Surgical implant and method for controlled release of chemotherapeutic agents |
US5306286A (en) * | 1987-06-25 | 1994-04-26 | Duke University | Absorbable stent |
US5306294A (en) * | 1992-08-05 | 1994-04-26 | Ultrasonic Sensing And Monitoring Systems, Inc. | Stent construction of rolled configuration |
US5383925A (en) * | 1992-09-14 | 1995-01-24 | Meadox Medicals, Inc. | Three-dimensional braided soft tissue prosthesis |
US5385580A (en) * | 1990-08-28 | 1995-01-31 | Meadox Medicals, Inc. | Self-supporting woven vascular graft |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5399666A (en) * | 1994-04-21 | 1995-03-21 | E. I. Du Pont De Nemours And Company | Easily degradable star-block copolymers |
US5502158A (en) * | 1988-08-08 | 1996-03-26 | Ecopol, Llc | Degradable polymer composition |
US5591199A (en) * | 1995-06-07 | 1997-01-07 | Porter; Christopher H. | Curable fiber composite stent and delivery system |
US5591607A (en) * | 1994-03-18 | 1997-01-07 | Lynx Therapeutics, Inc. | Oligonucleotide N3→P5' phosphoramidates: triplex DNA formation |
US5593403A (en) * | 1994-09-14 | 1997-01-14 | Scimed Life Systems Inc. | Method for modifying a stent in an implanted site |
US5593434A (en) * | 1992-01-31 | 1997-01-14 | Advanced Cardiovascular Systems, Inc. | Stent capable of attachment within a body lumen |
US5599301A (en) * | 1993-11-22 | 1997-02-04 | Advanced Cardiovascular Systems, Inc. | Motor control system for an automatic catheter inflation system |
US5605696A (en) * | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
US5607467A (en) * | 1990-09-14 | 1997-03-04 | Froix; Michael | Expandable polymeric stent with memory and delivery apparatus and method |
US5607442A (en) * | 1995-11-13 | 1997-03-04 | Isostent, Inc. | Stent with improved radiopacity and appearance characteristics |
US5618299A (en) * | 1993-04-23 | 1997-04-08 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
US5707385A (en) * | 1994-11-16 | 1998-01-13 | Advanced Cardiovascular Systems, Inc. | Drug loaded elastic membrane and method for delivery |
US5711763A (en) * | 1991-02-20 | 1998-01-27 | Tdk Corporation | Composite biological implant of a ceramic material in a metal substrate |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
US5725549A (en) * | 1994-03-11 | 1998-03-10 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5726297A (en) * | 1994-03-18 | 1998-03-10 | Lynx Therapeutics, Inc. | Oligodeoxyribonucleotide N3' P5' phosphoramidates |
US5728751A (en) * | 1996-11-25 | 1998-03-17 | Meadox Medicals, Inc. | Bonding bio-active materials to substrate surfaces |
US5733925A (en) * | 1993-01-28 | 1998-03-31 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5733330A (en) * | 1997-01-13 | 1998-03-31 | Advanced Cardiovascular Systems, Inc. | Balloon-expandable, crush-resistant locking stent |
US5733326A (en) * | 1996-05-28 | 1998-03-31 | Cordis Corporation | Composite material endoprosthesis |
US5733564A (en) * | 1993-04-14 | 1998-03-31 | Leiras Oy | Method of treating endo-osteal materials with a bisphosphonate solution |
US5741881A (en) * | 1996-11-25 | 1998-04-21 | Meadox Medicals, Inc. | Process for preparing covalently bound-heparin containing polyurethane-peo-heparin coating compositions |
US5855618A (en) * | 1996-09-13 | 1999-01-05 | Meadox Medicals, Inc. | Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin |
US5855612A (en) * | 1995-05-12 | 1999-01-05 | Ohta Inc. | Biocompatible titanium implant |
US5858746A (en) * | 1992-04-20 | 1999-01-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
US5865814A (en) * | 1995-06-07 | 1999-02-02 | Medtronic, Inc. | Blood contacting medical device and method |
US5868781A (en) * | 1996-10-22 | 1999-02-09 | Scimed Life Systems, Inc. | Locking stent |
US5874101A (en) * | 1997-04-14 | 1999-02-23 | Usbiomaterials Corp. | Bioactive-gel compositions and methods |
US5874109A (en) * | 1994-07-27 | 1999-02-23 | The Trustees Of The University Of Pennsylvania | Incorporation of biological molecules into bioactive glasses |
US5873904A (en) * | 1995-06-07 | 1999-02-23 | Cook Incorporated | Silver implantable medical device |
US5874165A (en) * | 1996-06-03 | 1999-02-23 | Gore Enterprise Holdings, Inc. | Materials and method for the immobilization of bioactive species onto polymeric subtrates |
US5877263A (en) * | 1996-11-25 | 1999-03-02 | Meadox Medicals, Inc. | Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents |
US5876743A (en) * | 1995-03-21 | 1999-03-02 | Den-Mat Corporation | Biocompatible adhesion in tissue repair |
US5879713A (en) * | 1994-10-12 | 1999-03-09 | Focal, Inc. | Targeted delivery via biodegradable polymers |
US5888533A (en) * | 1995-10-27 | 1999-03-30 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US5891192A (en) * | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
US6010445A (en) * | 1997-09-11 | 2000-01-04 | Implant Sciences Corporation | Radioactive medical device and process |
US6015541A (en) * | 1997-11-03 | 2000-01-18 | Micro Therapeutics, Inc. | Radioactive embolizing compositions |
US6022374A (en) * | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US6042875A (en) * | 1997-04-30 | 2000-03-28 | Schneider (Usa) Inc. | Drug-releasing coatings for medical devices |
US6171609B1 (en) * | 1995-02-15 | 2001-01-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6177523B1 (en) * | 1999-07-14 | 2001-01-23 | Cardiotech International, Inc. | Functionalized polyurethanes |
US6183505B1 (en) * | 1999-03-11 | 2001-02-06 | Medtronic Ave, Inc. | Method of stent retention to a delivery catheter balloon-braided retainers |
US6187045B1 (en) * | 1999-02-10 | 2001-02-13 | Thomas K. Fehring | Enhanced biocompatible implants and alloys |
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
US20020002399A1 (en) * | 1999-12-22 | 2002-01-03 | Huxel Shawn Thayer | Removable stent for body lumens |
US20020004060A1 (en) * | 1997-07-18 | 2002-01-10 | Bernd Heublein | Metallic implant which is degradable in vivo |
US20020004101A1 (en) * | 1995-04-19 | 2002-01-10 | Schneider (Usa) Inc. | Drug coating with topcoat |
US6506437B1 (en) * | 2000-10-17 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device having depots formed in a surface thereof |
US6511748B1 (en) * | 1998-01-06 | 2003-01-28 | Aderans Research Institute, Inc. | Bioabsorbable fibers and reinforced composites produced therefrom |
US6517888B1 (en) * | 2000-11-28 | 2003-02-11 | Scimed Life Systems, Inc. | Method for manufacturing a medical device having a coated portion by laser ablation |
US20030033001A1 (en) * | 2001-02-27 | 2003-02-13 | Keiji Igaki | Stent holding member and stent feeding system |
US6527801B1 (en) * | 2000-04-13 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Biodegradable drug delivery material for stent |
US6537589B1 (en) * | 2000-04-03 | 2003-03-25 | Kyung Won Medical Co., Ltd. | Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material |
US6676697B1 (en) * | 1996-09-19 | 2004-01-13 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US6679980B1 (en) * | 2001-06-13 | 2004-01-20 | Advanced Cardiovascular Systems, Inc. | Apparatus for electropolishing a stent |
US6689375B1 (en) * | 1999-11-09 | 2004-02-10 | Coripharm Medizinprodukte Gmbh & Co. Kg | Resorbable bone implant material and method for producing the same |
US6695920B1 (en) * | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
US6706273B1 (en) * | 1999-08-14 | 2004-03-16 | Ivoclar Vivadent Ag | Composition for implantation into the human and animal body |
US6709379B1 (en) * | 1998-11-02 | 2004-03-23 | Alcove Surfaces Gmbh | Implant with cavities containing therapeutic agents |
US20050004653A1 (en) * | 2003-06-19 | 2005-01-06 | Scimed Life Systems, Inc. | Sandwiched radiopaque marker on covered stent |
US20050015138A1 (en) * | 2003-05-22 | 2005-01-20 | Andreas Schuessler | Stent made of a material with low radio-opaqueness |
US6846323B2 (en) * | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
Family Cites Families (401)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2697863A (en) | 1952-04-09 | 1954-12-28 | Marietta A Moser | Pin fastener for furniture covers and the like |
US3476463A (en) | 1965-05-11 | 1969-11-04 | Perkin Elmer Corp | Coherent light optical system yielding an output beam of desired intensity distribution at a desired equiphase surface |
GB1237035A (en) | 1969-08-20 | 1971-06-30 | Tsi Travmatologii I Ortopedii | Magnesium-base alloy for use in bone surgery |
US3900632A (en) | 1970-02-27 | 1975-08-19 | Kimberly Clark Co | Laminate of tissue and random laid continuous filament web |
US3839743A (en) | 1972-04-21 | 1974-10-08 | A Schwarcz | Method for maintaining the normal integrity of blood |
US4104410A (en) | 1973-12-21 | 1978-08-01 | Malecki George J | Processing of green vegetables for color retention in canning |
US4110497A (en) | 1976-07-02 | 1978-08-29 | Snyder Manufacturing Co., Ltd. | Striped laminate and method and apparatus for making same |
DE2928007A1 (de) | 1979-07-11 | 1981-01-15 | Riess Guido Dr | Knochen-implantatkoerper fuer prothesen und knochenverbindungsstuecke sowie verfahren zu seiner herstellung |
US4346028A (en) | 1979-12-14 | 1982-08-24 | Monsanto Company | Asbestiform crystalline calcium sodium or lithium phosphate, preparation and compositions |
DE3019996A1 (de) | 1980-05-24 | 1981-12-03 | Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen | Hohlorgan |
US4517687A (en) | 1982-09-15 | 1985-05-21 | Meadox Medicals, Inc. | Synthetic woven double-velour graft |
US4594407A (en) | 1983-09-20 | 1986-06-10 | Allied Corporation | Prosthetic devices derived from krebs-cycle dicarboxylic acids and diols |
US4596574A (en) | 1984-05-14 | 1986-06-24 | The Regents Of The University Of California | Biodegradable porous ceramic delivery system for bone morphogenetic protein |
US4886870A (en) | 1984-05-21 | 1989-12-12 | Massachusetts Institute Of Technology | Bioerodible articles useful as implants and prostheses having predictable degradation rates |
CH671337A5 (de) | 1984-06-19 | 1989-08-31 | Ceskoslovenska Akademie Ved | |
US4879135A (en) | 1984-07-23 | 1989-11-07 | University Of Medicine And Dentistry Of New Jersey | Drug bonded prosthesis and process for producing same |
US5061281A (en) | 1985-12-17 | 1991-10-29 | Allied-Signal Inc. | Bioresorbable polymers and implantation devices thereof |
US4743252A (en) | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
EP0257091B1 (de) | 1986-02-24 | 1993-07-28 | Robert E. Fischell | Vorrichtung zum aufweisen von blutgefässen, sowie system zu deren einführung |
US4878906A (en) | 1986-03-25 | 1989-11-07 | Servetus Partnership | Endoprosthesis for repairing a damaged vessel |
EP0241838B1 (de) | 1986-04-07 | 1992-04-15 | Agency Of Industrial Science And Technology | Antithrombogenisches Material |
JPH0433791Y2 (de) | 1986-04-11 | 1992-08-12 | ||
US5527337A (en) | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
DK530787D0 (da) | 1987-10-09 | 1987-10-09 | Bukh Meditec | Indretning til indfoering i en legemshulhed |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4877030A (en) | 1988-02-02 | 1989-10-31 | Andreas Beck | Device for the widening of blood vessels |
AU4191989A (en) | 1988-08-24 | 1990-03-23 | Marvin J. Slepian | Biodegradable polymeric endoluminal sealing |
US5328471A (en) | 1990-02-26 | 1994-07-12 | Endoluminal Therapeutics, Inc. | Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens |
US5019090A (en) | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
FI85223C (fi) | 1988-11-10 | 1992-03-25 | Biocon Oy | Biodegraderande kirurgiska implant och medel. |
US4977901A (en) | 1988-11-23 | 1990-12-18 | Minnesota Mining And Manufacturing Company | Article having non-crosslinked crystallized polymer coatings |
CA2004833A1 (en) | 1988-12-08 | 1990-06-08 | Leonard Armand Trudell | Prosthesis of foam polyurethane and collagen and uses thereof |
CH678393A5 (de) | 1989-01-26 | 1991-09-13 | Ulrich Prof Dr Med Sigwart | |
EP0770874A3 (de) | 1989-01-27 | 1998-01-21 | Australian Membrane And Biotechnology Research Institute | Rezeptormembranen und selektive Steuerung des Ionenflusses durch Ionophoren |
US5163958A (en) | 1989-02-02 | 1992-11-17 | Cordis Corporation | Carbon coated tubular endoprosthesis |
NZ228382A (en) | 1989-03-17 | 1992-08-26 | Carter Holt Harvey Plastic Pro | Drug administering coil-like device for insertion in body cavity of animal |
US4990158A (en) | 1989-05-10 | 1991-02-05 | United States Surgical Corporation | Synthetic semiabsorbable tubular prosthesis |
EP0401844B1 (de) | 1989-06-09 | 1995-11-22 | Boehringer Ingelheim Kg | Resorbierbare Formkörper und Verfahren zu ihrer Herstellung |
US5971954A (en) | 1990-01-10 | 1999-10-26 | Rochester Medical Corporation | Method of making catheter |
DE69108423T2 (de) | 1990-02-08 | 1995-07-27 | Howmedica | Aufblasbarer Dilatator. |
US5545208A (en) | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US5156623A (en) | 1990-04-16 | 1992-10-20 | Olympus Optical Co., Ltd. | Sustained release material and method of manufacturing the same |
US5123917A (en) | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
DE69131574T2 (de) | 1990-05-14 | 2000-05-04 | Gary R Jernberg | Chirurgisches implantat und verfahren zum einbetten von chemotherapeutika |
EP0528993A1 (de) | 1990-05-18 | 1993-03-03 | STACK, Richard S. | Intravaskulärer stent |
JPH0433791A (ja) | 1990-05-29 | 1992-02-05 | Matsushita Electric Ind Co Ltd | レーザ加工装置 |
US6060451A (en) | 1990-06-15 | 2000-05-09 | The National Research Council Of Canada | Thrombin inhibitors based on the amino acid sequence of hirudin |
US5236447A (en) | 1990-06-29 | 1993-08-17 | Nissho Corporation | Artificial tubular organ |
US5342395A (en) | 1990-07-06 | 1994-08-30 | American Cyanamid Co. | Absorbable surgical repair devices |
US5112457A (en) | 1990-07-23 | 1992-05-12 | Case Western Reserve University | Process for producing hydroxylated plasma-polymerized films and the use of the films for enhancing the compatiblity of biomedical implants |
US5455040A (en) | 1990-07-26 | 1995-10-03 | Case Western Reserve University | Anticoagulant plasma polymer-modified substrate |
IL99296A (en) | 1990-08-28 | 1995-12-08 | Meadox Medicals Inc | A self-supported woven blood vessel implant and its preparation |
US5163952A (en) | 1990-09-14 | 1992-11-17 | Michael Froix | Expandable polymeric stent with memory and delivery apparatus and method |
JPH0717314Y2 (ja) | 1990-10-18 | 1995-04-26 | ソン ホーヨン | 自己膨張脈管内ステント |
CA2094908C (en) | 1990-12-06 | 2000-02-08 | Byron Kent Hayes | Implantable bioabsorbable article |
US5163951A (en) | 1990-12-27 | 1992-11-17 | Corvita Corporation | Mesh composite graft |
JP3199124B2 (ja) | 1990-12-28 | 2001-08-13 | 株式会社ニデック | レーザアブレーション装置 |
CS277367B6 (en) | 1990-12-29 | 1993-01-13 | Krajicek Milan | Three-layered vascular prosthesis |
SE9100610D0 (sv) | 1991-03-04 | 1991-03-04 | Procordia Ortech Ab | Bioresorbable material for medical use |
EP0528039B1 (de) | 1991-03-08 | 1999-07-07 | IGAKI, Keiji | Stent für gefässe, halterungsstruktur für diesen stent und vorrichtung zur montage desselben |
SE9101752D0 (sv) | 1991-06-10 | 1991-06-10 | Procordia Ortech Ab | Method of producing a microstructure in a bioresorbable element |
US5356433A (en) | 1991-08-13 | 1994-10-18 | Cordis Corporation | Biocompatible metal surfaces |
US5500013A (en) | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
WO1993006792A1 (en) | 1991-10-04 | 1993-04-15 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US5234457A (en) | 1991-10-09 | 1993-08-10 | Boston Scientific Corporation | Impregnated stent |
CA2121674C (en) | 1991-10-21 | 2003-05-06 | Timothy E. Trigg | Biocompatible implant for the timing of ovulation in mares |
US5167614A (en) | 1991-10-29 | 1992-12-01 | Medical Engineering Corporation | Prostatic stent |
DE69232640T2 (de) | 1991-11-06 | 2003-02-06 | Shui T Lai | Vorrichtung für hornhautchirurgie |
US5756476A (en) | 1992-01-14 | 1998-05-26 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of cell proliferation using antisense oligonucleotides |
EP0633798B1 (de) | 1992-03-31 | 2003-05-07 | Boston Scientific Corporation | Blutgefässfilter |
DE4222380A1 (de) | 1992-07-08 | 1994-01-13 | Ernst Peter Prof Dr M Strecker | In den Körper eines Patienten perkutan implantierbare Endoprothese |
US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
AU664913B2 (en) | 1992-08-13 | 1995-12-07 | Implico B.V. | A hydrogel composition and methods of making it |
US5853408A (en) | 1992-08-20 | 1998-12-29 | Advanced Cardiovascular Systems, Inc. | In-vivo modification of the mechanical properties of surgical devices |
US5342621A (en) | 1992-09-15 | 1994-08-30 | Advanced Cardiovascular Systems, Inc. | Antithrombogenic surface |
US5770609A (en) | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US5830461A (en) | 1992-11-25 | 1998-11-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods for promoting wound healing and treating transplant-associated vasculopathy |
US5342348A (en) | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
US5380976A (en) | 1992-12-11 | 1995-01-10 | Hypertherm, Inc. | Process for high quality plasma arc and laser cutting of stainless steel and aluminum |
US5443458A (en) | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
EP0604022A1 (de) | 1992-12-22 | 1994-06-29 | Advanced Cardiovascular Systems, Inc. | Mehrschichtiges resorbierbares Stent und Verfahren zu dessen Herstellung |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
JP3583801B2 (ja) | 1993-03-03 | 2004-11-04 | ボストン サイエンティフィック リミテッド | 管腔用のステントおよび移植体 |
WO1994021196A2 (en) | 1993-03-18 | 1994-09-29 | C.R. Bard, Inc. | Endovascular stents |
US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
EG20321A (en) | 1993-07-21 | 1998-10-31 | Otsuka Pharma Co Ltd | Medical material and process for producing the same |
US5565215A (en) | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
KR100316863B1 (ko) | 1993-07-23 | 2002-09-26 | 쿠크 인코포레이티드 | 판형재료로형성된패턴을가진가요성스텐트 |
KR100329409B1 (ko) | 1993-08-26 | 2002-03-20 | 브루스 엠. 에이센, 토마스 제이 데스로저 | 인간 골 형태발생 단백질을 사용한 신경 재생법 |
DE59308451D1 (de) | 1993-10-20 | 1998-05-28 | Schneider Europ Ag | Endoprothese |
US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
JPH07124766A (ja) | 1993-11-04 | 1995-05-16 | Hitachi Ltd | エキシマレーザ加工制御方法 |
SE501288C2 (sv) | 1993-11-30 | 1995-01-09 | Corimed Gmbh | Förfarande för framställning av keramiskt implantatmaterial, företrädesvis hydroxylapatit uppvisande keramiskt implantatmaterial |
US5626611A (en) | 1994-02-10 | 1997-05-06 | United States Surgical Corporation | Composite bioabsorbable materials and surgical articles made therefrom |
EP0804249A2 (de) | 1994-03-15 | 1997-11-05 | Brown University Research Foundation | Polymeres system zur freisetzung von genen |
US5965720A (en) | 1994-03-18 | 1999-10-12 | Lynx Therapeutics, Inc. | Oligonucleotide N3'→P5' phosphoramidates |
US5656186A (en) | 1994-04-08 | 1997-08-12 | The Regents Of The University Of Michigan | Method for controlling configuration of laser induced breakdown and ablation |
JP2825452B2 (ja) | 1994-04-25 | 1998-11-18 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | ラジオパク・ステント・マーカ |
EP0754017B1 (de) | 1994-04-29 | 2002-06-19 | SciMed Life Systems, Inc. | Stent mit kollagen |
US5629077A (en) | 1994-06-27 | 1997-05-13 | Advanced Cardiovascular Systems, Inc. | Biodegradable mesh and film stent |
US5670558A (en) | 1994-07-07 | 1997-09-23 | Terumo Kabushiki Kaisha | Medical instruments that exhibit surface lubricity when wetted |
US6007845A (en) | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
US5554120A (en) | 1994-07-25 | 1996-09-10 | Advanced Cardiovascular Systems, Inc. | Polymer blends for use in making medical devices including catheters and balloons for dilatation catheters |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5578073A (en) | 1994-09-16 | 1996-11-26 | Ramot Of Tel Aviv University | Thromboresistant surface treatment for biomaterials |
US5649977A (en) | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
US5765682A (en) | 1994-10-13 | 1998-06-16 | Menlo Care, Inc. | Restrictive package for expandable or shape memory medical devices and method of preventing premature change of same |
IL115755A0 (en) | 1994-10-27 | 1996-01-19 | Medinol Ltd | X-ray visible stent |
US5836964A (en) | 1996-10-30 | 1998-11-17 | Medinol Ltd. | Stent fabrication method |
CA2301351C (en) | 1994-11-28 | 2002-01-22 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
US5637113A (en) | 1994-12-13 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | Polymer film for wrapping a stent structure |
US6017577A (en) | 1995-02-01 | 2000-01-25 | Schneider (Usa) Inc. | Slippery, tenaciously adhering hydrophilic polyurethane hydrogel coatings, coated polymer substrate materials, and coated medical devices |
US5919570A (en) | 1995-02-01 | 1999-07-06 | Schneider Inc. | Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly(N-vinylpyrrolidone) polymer hydrogel, coated polymer and metal substrate materials, and coated medical devices |
US6120536A (en) | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US5954744A (en) | 1995-06-06 | 1999-09-21 | Quanam Medical Corporation | Intravascular stent |
US5603722A (en) | 1995-06-06 | 1997-02-18 | Quanam Medical Corporation | Intravascular stent |
US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US5667767A (en) | 1995-07-27 | 1997-09-16 | Micro Therapeutics, Inc. | Compositions for use in embolizing blood vessels |
GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
US5686540A (en) | 1995-09-29 | 1997-11-11 | Dainippon Ink And Chemicals, Inc. | Process for the preparation of lactic acid-based polyester |
US5830879A (en) | 1995-10-02 | 1998-11-03 | St. Elizabeth's Medical Center Of Boston, Inc. | Treatment of vascular injury using vascular endothelial growth factor |
US6048964A (en) | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
EP1704878B1 (de) | 1995-12-18 | 2013-04-10 | AngioDevice International GmbH | Quervernetzte Polymerzusammensetzungen und Verfahren zu ihrer Verwendung |
DE69732794T2 (de) | 1996-01-05 | 2006-04-06 | Medtronic, Inc., Minneapolis | Expandierbare endoluminale prothesen |
US6150630A (en) | 1996-01-11 | 2000-11-21 | The Regents Of The University Of California | Laser machining of explosives |
JP2001502605A (ja) | 1996-01-30 | 2001-02-27 | メドトロニック,インコーポレーテッド | ステントを作るための物品および方法 |
JP2000509014A (ja) | 1996-03-11 | 2000-07-18 | フォーカル,インコーポレイテッド | 放射性核種および放射性医薬品のポリマー送達 |
IL117472A0 (en) | 1996-03-13 | 1996-07-23 | Instent Israel Ltd | Radiopaque stent markers |
US5824042A (en) | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
US6071266A (en) | 1996-04-26 | 2000-06-06 | Kelley; Donald W. | Lubricious medical devices |
US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
US6592617B2 (en) | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US5670161A (en) | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
US5914182A (en) | 1996-06-03 | 1999-06-22 | Gore Hybrid Technologies, Inc. | Materials and methods for the immobilization of bioactive species onto polymeric substrates |
US5830178A (en) | 1996-10-11 | 1998-11-03 | Micro Therapeutics, Inc. | Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide |
GB9616032D0 (en) | 1996-07-31 | 1996-09-11 | Ici Plc | Cassette casing for thermal transfer printing dye ribbon |
US5800516A (en) | 1996-08-08 | 1998-09-01 | Cordis Corporation | Deployable and retrievable shape memory stent/tube and method |
US6174329B1 (en) | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
US6344271B1 (en) | 1998-11-06 | 2002-02-05 | Nanoenergy Corporation | Materials and products using nanostructured non-stoichiometric substances |
US6174326B1 (en) | 1996-09-25 | 2001-01-16 | Terumo Kabushiki Kaisha | Radiopaque, antithrombogenic stent and method for its production |
EP0842729A1 (de) | 1996-10-21 | 1998-05-20 | Arterial Vascular Engineering, Inc. | Verfahren und Vorrichtung zur Behandlung von intravenösen Vorrichtungen |
US6387121B1 (en) | 1996-10-21 | 2002-05-14 | Inflow Dynamics Inc. | Vascular and endoluminal stents with improved coatings |
US5833651A (en) | 1996-11-08 | 1998-11-10 | Medtronic, Inc. | Therapeutic intraluminal stents |
US5704082A (en) | 1996-11-26 | 1998-01-06 | Smith; Catherine V. | Anchor pin for dust ruffle |
JPH10166156A (ja) | 1996-12-06 | 1998-06-23 | Hitachi Zosen Corp | プラズマ切断装置 |
IT1289728B1 (it) | 1996-12-10 | 1998-10-16 | Sorin Biomedica Cardio Spa | Dispositivo di impianto e corredo che lo comprende |
US6206911B1 (en) | 1996-12-19 | 2001-03-27 | Simcha Milo | Stent combination |
US5980972A (en) | 1996-12-20 | 1999-11-09 | Schneider (Usa) Inc | Method of applying drug-release coatings |
US5906759A (en) | 1996-12-26 | 1999-05-25 | Medinol Ltd. | Stent forming apparatus with stent deforming blades |
IT1291001B1 (it) | 1997-01-09 | 1998-12-14 | Sorin Biomedica Cardio Spa | Stent per angioplastica e suo procedimento di produzione |
US6159951A (en) | 1997-02-13 | 2000-12-12 | Ribozyme Pharmaceuticals Inc. | 2'-O-amino-containing nucleoside analogs and polynucleotides |
US6582472B2 (en) | 1997-02-26 | 2003-06-24 | Applied Medical Resources Corporation | Kinetic stent |
AU6946198A (en) | 1997-04-01 | 1998-10-22 | Cap Biotechnology, Inc. | Calcium phosphate microcarriers and microspheres |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
FI103715B (fi) | 1997-04-21 | 1999-08-31 | Vivoxid Oy | Uusi komposiitti ja sen käyttö |
US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US6610764B1 (en) | 1997-05-12 | 2003-08-26 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
US6303901B1 (en) | 1997-05-20 | 2001-10-16 | The Regents Of The University Of California | Method to reduce damage to backing plate |
US6056993A (en) | 1997-05-30 | 2000-05-02 | Schneider (Usa) Inc. | Porous protheses and methods for making the same wherein the protheses are formed by spraying water soluble and water insoluble fibers onto a rotating mandrel |
US6110483A (en) | 1997-06-23 | 2000-08-29 | Sts Biopolymers, Inc. | Adherent, flexible hydrogel and medicated coatings |
JP3844848B2 (ja) | 1997-06-24 | 2006-11-15 | 三菱電機株式会社 | レーザ加工機 |
US5980928A (en) | 1997-07-29 | 1999-11-09 | Terry; Paul B. | Implant for preventing conjunctivitis in cattle |
US6340367B1 (en) | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US6245103B1 (en) | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
US5980564A (en) | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
US6121027A (en) | 1997-08-15 | 2000-09-19 | Surmodics, Inc. | Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups |
US6117979A (en) | 1997-08-18 | 2000-09-12 | Medtronic, Inc. | Process for making a bioprosthetic device and implants produced therefrom |
US6129928A (en) | 1997-09-05 | 2000-10-10 | Icet, Inc. | Biomimetic calcium phosphate implant coatings and methods for making the same |
US6284333B1 (en) | 1997-09-10 | 2001-09-04 | Scimed Life Systems, Inc. | Medical devices made from polymer blends containing low melting temperature liquid crystal polymers |
EP1030913A2 (de) | 1997-09-22 | 2000-08-30 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Katalytische nukleinsäuren mit endonuklease aktivität |
US6231598B1 (en) | 1997-09-24 | 2001-05-15 | Med Institute, Inc. | Radially expandable stent |
US6042606A (en) | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US5972027A (en) | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
US5976182A (en) | 1997-10-03 | 1999-11-02 | Advanced Cardiovascular Systems, Inc. | Balloon-expandable, crush-resistant locking stent and method of loading the same |
DE19745294A1 (de) | 1997-10-14 | 1999-04-15 | Biotronik Mess & Therapieg | Verfahren zur Herstellung feinstrukturierter medizintechnischer Implantate |
US7128737B1 (en) | 1997-10-22 | 2006-10-31 | Carl Zeiss Meditec Ag | Object figuring device |
DE29724852U1 (de) | 1997-10-22 | 2005-01-13 | Carl Zeiss Meditec Ag | Vorrichtung zur Formgebung von Objekten |
DE19746882A1 (de) | 1997-10-23 | 1999-04-29 | Angiomed Ag | Aufgeweiteter Stent und Verfahren zum Herstellen desselben |
EP1035879B1 (de) | 1997-11-24 | 2003-06-11 | EFMT Entwicklungs- und Forschungszentrum für Mikrotherapie gGmbH | Verfahren zur immobilisierung von mediatormolekülen auf anorganischen und metallischen implantatmaterialien |
US6156062A (en) | 1997-12-03 | 2000-12-05 | Ave Connaught | Helically wrapped interlocking stent |
US6093463A (en) | 1997-12-12 | 2000-07-25 | Intella Interventional Systems, Inc. | Medical devices made from improved polymer blends |
US5957975A (en) | 1997-12-15 | 1999-09-28 | The Cleveland Clinic Foundation | Stent having a programmed pattern of in vivo degradation |
US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US5986169A (en) | 1997-12-31 | 1999-11-16 | Biorthex Inc. | Porous nickel-titanium alloy article |
US6503271B2 (en) | 1998-01-09 | 2003-01-07 | Cordis Corporation | Intravascular device with improved radiopacity |
US6224626B1 (en) | 1998-02-17 | 2001-05-01 | Md3, Inc. | Ultra-thin expandable stent |
JP3732404B2 (ja) | 1998-02-23 | 2006-01-05 | ニーモサイエンス ゲーエムベーハー | 形状記憶ポリマー組成物、形状記憶製品を形成する方法、および形状を記憶する組成物を形成する方法 |
DE69917224T2 (de) | 1998-02-23 | 2004-09-09 | Massachusetts Institute Of Technology, Cambridge | Bioabbaubare polymere mit formgedächtnis |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6110188A (en) | 1998-03-09 | 2000-08-29 | Corvascular, Inc. | Anastomosis method |
US6656215B1 (en) | 2000-11-16 | 2003-12-02 | Cordis Corporation | Stent graft having an improved means for attaching a stent to a graft |
US7208010B2 (en) * | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US6563998B1 (en) | 1999-04-15 | 2003-05-13 | John Farah | Polished polymide substrate |
US6113629A (en) | 1998-05-01 | 2000-09-05 | Micrus Corporation | Hydrogel for the therapeutic treatment of aneurysms |
US6083258A (en) | 1998-05-28 | 2000-07-04 | Yadav; Jay S. | Locking stent |
EP0966979B1 (de) | 1998-06-25 | 2006-03-08 | Biotronik AG | Implantierbare, bioresorbierbare Gefässwandstütze, insbesondere Koronarstent |
DE19856983A1 (de) | 1998-06-25 | 1999-12-30 | Biotronik Mess & Therapieg | Implantierbare, bioresorbierbare Gefäßwandstütze, insbesondere Koronarstent |
US6153252A (en) | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
US20050283228A1 (en) | 1998-07-29 | 2005-12-22 | Stanford Ulf H | Expandable stent with relief holes capable of carrying medicines and other materials |
CA2338788A1 (en) | 1998-09-02 | 2000-03-09 | Scimed Life Systems, Inc. | Drug delivery device for stent |
ES2185227T3 (es) | 1998-10-19 | 2003-04-16 | Synthes Ag | Cemento hidraulico ceramico que endurece. |
EP1000958B1 (de) | 1998-11-12 | 2004-03-17 | Takiron Co. Ltd. | Bioabbaubares, absorbierbares Formgedächtnismaterial |
US6125523A (en) | 1998-11-20 | 2000-10-03 | Advanced Cardiovascular Systems, Inc. | Stent crimping tool and method of use |
US6350277B1 (en) | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
DE60038474T2 (de) | 1999-01-22 | 2009-04-30 | Gore Enterprise Holdings, Inc., Newark | Kombination aus stent und transplantat mit niedrigem profil |
DE60017363T2 (de) | 1999-02-02 | 2006-03-02 | Wright Medical Technology Inc., Arlington | Kontrollierte freisetzung eines verbundmaterials |
US6361557B1 (en) | 1999-02-05 | 2002-03-26 | Medtronic Ave, Inc. | Staplebutton radiopaque marker |
US6066156A (en) | 1999-03-11 | 2000-05-23 | Advanced Cardiovascular Systems, Inc. | Temperature activated adhesive for releasably attaching stents to balloons |
US6730116B1 (en) | 1999-04-16 | 2004-05-04 | Medtronic, Inc. | Medical device for intraluminal endovascular stenting |
AU4975500A (en) | 1999-04-23 | 2000-11-10 | Agion Technologies, Llc | Stent having antimicrobial agent |
US6368346B1 (en) | 1999-06-03 | 2002-04-09 | American Medical Systems, Inc. | Bioresorbable stent |
US6667049B2 (en) | 1999-06-14 | 2003-12-23 | Ethicon, Inc. | Relic process for producing bioresorbable ceramic tissue scaffolds |
US6312459B1 (en) | 1999-06-30 | 2001-11-06 | Advanced Cardiovascular Systems, Inc. | Stent design for use in small vessels |
US6258121B1 (en) | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
AUPQ170799A0 (en) | 1999-07-20 | 1999-08-12 | Cardiac Crc Nominees Pty Limited | Shape memory polyurethane or polyurethane-urea polymers |
US6569193B1 (en) | 1999-07-22 | 2003-05-27 | Advanced Cardiovascular Systems, Inc. | Tapered self-expanding stent |
CN1241442A (zh) | 1999-07-27 | 2000-01-19 | 林代平 | 术后防粘连方法 |
US6479565B1 (en) | 1999-08-16 | 2002-11-12 | Harold R. Stanley | Bioactive ceramic cement |
US6379381B1 (en) | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
JP4172883B2 (ja) | 1999-09-08 | 2008-10-29 | Hoya株式会社 | 薬物徐放用担体および薬物徐放用担体の製造方法 |
US6283234B1 (en) | 1999-09-17 | 2001-09-04 | Sylvan Engineering Company | Apparatus for mounting PCD compacts |
WO2001026584A1 (en) | 1999-10-14 | 2001-04-19 | United Stenting, Inc. | Stents with multilayered struts |
US7226475B2 (en) | 1999-11-09 | 2007-06-05 | Boston Scientific Scimed, Inc. | Stent with variable properties |
EP1229901B1 (de) | 1999-11-17 | 2009-03-18 | Boston Scientific Limited | Miniaturisierte vorrichtungen zur abgabe von molekülen in einer trägerflüssigkeit |
US7947069B2 (en) | 1999-11-24 | 2011-05-24 | University Of Washington | Medical devices comprising small fiber biomaterials, and methods of use |
US6554854B1 (en) | 1999-12-10 | 2003-04-29 | Scimed Life Systems, Inc. | Process for laser joining dissimilar metals and endoluminal stent with radiopaque marker produced thereby |
US6295168B1 (en) | 1999-12-15 | 2001-09-25 | International Business Machines Corporation | Refractive optical system that converts a laser beam to a collimated flat-top beam |
US6654183B2 (en) | 1999-12-15 | 2003-11-25 | International Business Machines Corporation | System for converting optical beams to collimated flat-top beams |
US6338739B1 (en) | 1999-12-22 | 2002-01-15 | Ethicon, Inc. | Biodegradable stent |
US6494908B1 (en) | 1999-12-22 | 2002-12-17 | Ethicon, Inc. | Removable stent for body lumens |
US6471721B1 (en) * | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
US6355058B1 (en) | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
AU781910B2 (en) | 2000-01-28 | 2005-06-23 | Cook Medical Technologies Llc | Endovascular medical device with plurality of wires |
US6375826B1 (en) | 2000-02-14 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Electro-polishing fixture and electrolyte solution for polishing stents and method |
EP1153621A1 (de) | 2000-05-12 | 2001-11-14 | MERCK PATENT GmbH | Biozemente auf TCP-PHA-Basismischung mit verbesserter Kompressionsfestigkeit |
US7394591B2 (en) | 2000-05-23 | 2008-07-01 | Imra America, Inc. | Utilization of Yb: and Nd: mode-locked oscillators in solid-state short pulse laser systems |
US6395326B1 (en) | 2000-05-31 | 2002-05-28 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for depositing a coating onto a surface of a prosthesis |
US6652579B1 (en) | 2000-06-22 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent |
IL137090A (en) | 2000-06-29 | 2010-04-15 | Pentech Medical Devices Ltd | Polymeric stent |
US6585765B1 (en) * | 2000-06-29 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Implantable device having substances impregnated therein and a method of impregnating the same |
US6974473B2 (en) | 2000-06-30 | 2005-12-13 | Vascular Architects, Inc. | Function-enhanced thrombolytic AV fistula and method |
US6716252B2 (en) | 2000-06-30 | 2004-04-06 | Wit Ip Corporation | Prostatic stent with localized tissue engaging anchoring means and methods for inhibiting obstruction of the prostatic urethra |
US9387094B2 (en) | 2000-07-19 | 2016-07-12 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US6569191B1 (en) | 2000-07-27 | 2003-05-27 | Bionx Implants, Inc. | Self-expanding stent with enhanced radial expansion and shape memory |
US6574851B1 (en) | 2000-07-31 | 2003-06-10 | Advanced Cardiovascular Systems, Inc. | Stent made by rotational molding or centrifugal casting and method for making the same |
GB0020491D0 (en) | 2000-08-18 | 2000-10-11 | Angiomed Ag | Stent with attached element and method of making such a stent |
US6699278B2 (en) | 2000-09-22 | 2004-03-02 | Cordis Corporation | Stent with optimal strength and radiopacity characteristics |
WO2002026162A2 (en) * | 2000-09-26 | 2002-04-04 | Advanced Cardiovascular Systems, Inc. | A method of loading a substance onto an implantable device |
US6485512B1 (en) | 2000-09-27 | 2002-11-26 | Advanced Cardiovascular Systems, Inc. | Two-stage light curable stent and delivery system |
US6805898B1 (en) | 2000-09-28 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Surface features of an implantable medical device |
US6254632B1 (en) | 2000-09-28 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Implantable medical device having protruding surface structures for drug delivery and cover attachment |
US20020111590A1 (en) | 2000-09-29 | 2002-08-15 | Davila Luis A. | Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
US20070276476A1 (en) | 2000-09-29 | 2007-11-29 | Llanos Gerard H | Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon |
US6746773B2 (en) | 2000-09-29 | 2004-06-08 | Ethicon, Inc. | Coatings for medical devices |
US6863685B2 (en) * | 2001-03-29 | 2005-03-08 | Cordis Corporation | Radiopacity intraluminal medical device |
US6492615B1 (en) | 2000-10-12 | 2002-12-10 | Scimed Life Systems, Inc. | Laser polishing of medical devices |
WO2003061502A1 (en) | 2000-10-26 | 2003-07-31 | Scimed Life Systems, Inc. | Stent having radiopaque markers and method of fabricating the same |
US6758859B1 (en) | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
FR2816227B1 (fr) | 2000-11-09 | 2003-01-24 | Air Liquide | Procede de coupage laser a haute vitesse avec gaz adapte |
US10398830B2 (en) * | 2000-11-17 | 2019-09-03 | Vactronix Scientific, Llc | Device for in vivo delivery of bioactive agents and method of manufacture thereof |
US6664335B2 (en) | 2000-11-30 | 2003-12-16 | Cardiac Pacemakers, Inc. | Polyurethane elastomer article with “shape memory” and medical devices therefrom |
JP3881508B2 (ja) | 2000-12-04 | 2007-02-14 | 株式会社ニデック | レーザ治療装置 |
DE10064596A1 (de) | 2000-12-18 | 2002-06-20 | Biotronik Mess & Therapieg | Verfahren zum Anbringen eines Markerelements an einem Implantat sowie mit einem Markerelement versehenes Implantat |
US6565599B1 (en) | 2000-12-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Hybrid stent |
US6641607B1 (en) * | 2000-12-29 | 2003-11-04 | Advanced Cardiovascular Systems, Inc. | Double tube stent |
JP4815057B2 (ja) * | 2001-02-13 | 2011-11-16 | 株式会社カネカ | ステント |
US6563080B2 (en) | 2001-02-15 | 2003-05-13 | Scimed Life Systems, Inc. | Laser cutting of stents and other medical devices |
US6540777B2 (en) | 2001-02-15 | 2003-04-01 | Scimed Life Systems, Inc. | Locking stent |
US20030069630A1 (en) | 2001-03-02 | 2003-04-10 | Robert Burgermeister | Stent with radiopaque markers incorporated thereon |
WO2002074481A1 (en) | 2001-03-16 | 2002-09-26 | Laser Machining, Inc. | Laser ablation technique |
US6764505B1 (en) | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
US6913762B2 (en) | 2001-04-25 | 2005-07-05 | Mayo Foundation For Medical Education And Research | Stent having non-woven framework containing cells |
WO2002087586A1 (en) | 2001-04-26 | 2002-11-07 | Control Delivery Systems, Inc. | Sustained release drug delivery system containing codrugs |
US8182527B2 (en) | 2001-05-07 | 2012-05-22 | Cordis Corporation | Heparin barrier coating for controlled drug release |
US6521865B1 (en) | 2001-06-14 | 2003-02-18 | Advanced Cardiovascular Systems, Inc. | Pulsed fiber laser cutting system for medical implants |
US6673106B2 (en) | 2001-06-14 | 2004-01-06 | Cordis Neurovascular, Inc. | Intravascular stent device |
US6585755B2 (en) | 2001-06-29 | 2003-07-01 | Advanced Cardiovascular | Polymeric stent suitable for imaging by MRI and fluoroscopy |
DE60120955T3 (de) * | 2001-07-20 | 2015-06-25 | Cid S.P.A. | Stent |
US6926733B2 (en) | 2001-08-02 | 2005-08-09 | Boston Scientific Scimed, Inc. | Method for enhancing sheet or tubing metal stent radiopacity |
DE10138866B4 (de) | 2001-08-08 | 2007-05-16 | Bosch Gmbh Robert | Verfahren zum Bohren eines Lochs in ein Werkstück mittels Laserstrahls |
JP2003053577A (ja) | 2001-08-15 | 2003-02-26 | Sumitomo Heavy Ind Ltd | トップフラットビームの生成方法、装置、及び、これを用いたレーザ加工方法、装置 |
US7252679B2 (en) | 2001-09-13 | 2007-08-07 | Cordis Corporation | Stent with angulated struts |
IN2014DN10834A (de) | 2001-09-17 | 2015-09-04 | Psivida Inc | |
US20030060872A1 (en) | 2001-09-26 | 2003-03-27 | Gary Gomringer | Stent with radiopaque characteristics |
EP1429833B1 (de) | 2001-09-28 | 2018-02-14 | Boston Scientific Limited | Katheter mit nanokompositen |
US20040143180A1 (en) | 2001-11-27 | 2004-07-22 | Sheng-Ping Zhong | Medical devices visible under magnetic resonance imaging |
US7014654B2 (en) * | 2001-11-30 | 2006-03-21 | Scimed Life Systems, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
US20030105530A1 (en) * | 2001-12-04 | 2003-06-05 | Inion Ltd. | Biodegradable implant and method for manufacturing one |
US20060204556A1 (en) | 2001-12-07 | 2006-09-14 | Cytori Therapeutics, Inc. | Cell-loaded prostheses for regenerative intraluminal applications |
US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
CN1241442C (zh) | 2001-12-14 | 2006-02-08 | 广达电脑股份有限公司 | 手机内藏式天线模块 |
US6866805B2 (en) | 2001-12-27 | 2005-03-15 | Advanced Cardiovascular Systems, Inc. | Hybrid intravascular stent |
US7326245B2 (en) | 2002-01-31 | 2008-02-05 | Boston Scientific Scimed, Inc. | Medical device for delivering biologically active material |
US20030153971A1 (en) | 2002-02-14 | 2003-08-14 | Chandru Chandrasekaran | Metal reinforced biodegradable intraluminal stents |
US20030155328A1 (en) | 2002-02-15 | 2003-08-21 | Huth Mark C. | Laser micromachining and methods and systems of same |
US7691461B1 (en) | 2002-04-01 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Hybrid stent and method of making |
US20030187495A1 (en) | 2002-04-01 | 2003-10-02 | Cully Edward H. | Endoluminal devices, embolic filters, methods of manufacture and use |
US7083822B2 (en) | 2002-04-26 | 2006-08-01 | Medtronic Vascular, Inc. | Overlapping coated stents |
US7270675B2 (en) | 2002-05-10 | 2007-09-18 | Cordis Corporation | Method of forming a tubular membrane on a structural frame |
DE10222117B4 (de) | 2002-05-17 | 2004-09-16 | W&H Dentalwerk Bürmoos Gesellschaft m.b.H. | Dentalmedizinisches Laserbearbeitungsgerät zur plasmainduzierten Ablation |
US20030236563A1 (en) | 2002-06-20 | 2003-12-25 | Dan Fifer | Stent delivery catheter with retention bands |
US6780261B2 (en) | 2002-06-27 | 2004-08-24 | Scimed Life Systems, Inc. | Method of manufacturing an implantable stent having improved mechanical properties |
US7141063B2 (en) | 2002-08-06 | 2006-11-28 | Icon Medical Corp. | Stent with micro-latching hinge joints |
US7151532B2 (en) | 2002-08-09 | 2006-12-19 | 3M Innovative Properties Company | Multifunctional multilayer optical film |
US6945995B2 (en) | 2002-08-29 | 2005-09-20 | Boston Scientific Scimed, Inc. | Stent overlap point markers |
AU2003254132A1 (en) | 2002-08-30 | 2004-03-19 | Advanced Cardiovascular Systems, Inc. | Stent with nested rings |
US20040044399A1 (en) | 2002-09-04 | 2004-03-04 | Ventura Joseph A. | Radiopaque links for self-expanding stents |
JP2005538780A (ja) | 2002-09-13 | 2005-12-22 | リンバテック・コーポレイション | 延伸および拡張されたステント |
US7001422B2 (en) | 2002-09-23 | 2006-02-21 | Cordis Neurovascular, Inc | Expandable stent and delivery system |
US6818063B1 (en) | 2002-09-24 | 2004-11-16 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for minimizing coating defects |
US7331986B2 (en) | 2002-10-09 | 2008-02-19 | Boston Scientific Scimed, Inc. | Intraluminal medical device having improved visibility |
US20040088039A1 (en) * | 2002-11-01 | 2004-05-06 | Lee Nathan T. | Method of securing radiopaque markers to an implant |
US20040098090A1 (en) | 2002-11-14 | 2004-05-20 | Williams Michael S. | Polymeric endoprosthesis and method of manufacture |
US6696667B1 (en) | 2002-11-22 | 2004-02-24 | Scimed Life Systems, Inc. | Laser stent cutting |
US7491234B2 (en) | 2002-12-03 | 2009-02-17 | Boston Scientific Scimed, Inc. | Medical devices for delivery of therapeutic agents |
US7776926B1 (en) | 2002-12-11 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for implantable medical devices |
US6899729B1 (en) | 2002-12-18 | 2005-05-31 | Advanced Cardiovascular Systems, Inc. | Stent for treating vulnerable plaque |
US8088158B2 (en) | 2002-12-20 | 2012-01-03 | Boston Scientific Scimed, Inc. | Radiopaque ePTFE medical devices |
US6852946B2 (en) | 2002-12-20 | 2005-02-08 | Caterpillar Inc | Laser-induced plasma micromachining |
US7455687B2 (en) | 2002-12-30 | 2008-11-25 | Advanced Cardiovascular Systems, Inc. | Polymer link hybrid stent |
US20040126405A1 (en) | 2002-12-30 | 2004-07-01 | Scimed Life Systems, Inc. | Engineered scaffolds for promoting growth of cells |
DE10300475B4 (de) | 2003-01-09 | 2008-11-13 | Alveolus Inc. | Stent mit einem tubulären aufweitbaren Stützgerät |
US20040143317A1 (en) | 2003-01-17 | 2004-07-22 | Stinson Jonathan S. | Medical devices |
US20040143338A1 (en) | 2003-01-21 | 2004-07-22 | Brian Burkinshaw | Multi-piece modular patellar prosthetic system |
US20040249442A1 (en) | 2003-02-26 | 2004-12-09 | Fleming James A. | Locking stent having multiple locking points |
US20040167610A1 (en) | 2003-02-26 | 2004-08-26 | Fleming James A. | Locking stent |
WO2004075789A2 (en) | 2003-02-26 | 2004-09-10 | Cook Incorporated | PROTHESIS ADAPTED FOR PLACEDd UNDER EXTERNAL IMAGING |
US7487579B2 (en) | 2003-03-12 | 2009-02-10 | Boston Scientific Scimed, Inc. | Methods of making medical devices |
US7163555B2 (en) | 2003-04-08 | 2007-01-16 | Medtronic Vascular, Inc. | Drug-eluting stent for controlled drug delivery |
US7625398B2 (en) | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US8048146B2 (en) | 2003-05-06 | 2011-11-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20040236409A1 (en) | 2003-05-20 | 2004-11-25 | Pelton Alan R. | Radiopacity intraluminal medical device |
US20050211680A1 (en) | 2003-05-23 | 2005-09-29 | Mingwei Li | Systems and methods for laser texturing of surfaces of a substrate |
DE10325678A1 (de) | 2003-06-02 | 2004-12-23 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Verbindungssystem zur Verbindung eines Stents mit einem radioopaken Marker sowie Verfahren zur Herstellung einer Verbindung zwischen einem Stent und zwei oder mehreren radioopaken Markern |
US20050021131A1 (en) | 2003-06-16 | 2005-01-27 | Subramanian Venkatraman | Polymeric stent and method of manufacture |
WO2004112863A1 (en) | 2003-06-20 | 2004-12-29 | Mcgill University | Biodegradable membrane-covered implant comprising chitosan |
US7166099B2 (en) | 2003-08-21 | 2007-01-23 | Boston Scientific Scimed, Inc. | Multilayer medical devices |
DE10340931A1 (de) | 2003-09-05 | 2005-03-31 | Herbert Walter | Verfahren und Vorrichtung zum Bohren feinster Löcher |
US20050060025A1 (en) * | 2003-09-12 | 2005-03-17 | Mackiewicz David A. | Radiopaque markers for medical devices |
US20050087520A1 (en) | 2003-10-28 | 2005-04-28 | Lixiao Wang | Method and apparatus for selective ablation of coatings from medical devices |
US8309112B2 (en) | 2003-12-24 | 2012-11-13 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same |
DE10361942A1 (de) | 2003-12-24 | 2005-07-21 | Restate Patent Ag | Radioopaker Marker für medizinische Implantate |
CN1926728A (zh) | 2004-01-07 | 2007-03-07 | 光谱物理学公司 | 工业用直接二极管泵浦超快速放大器系统 |
US7284401B2 (en) | 2004-01-12 | 2007-10-23 | Boston Scientific Scimed, Inc. | Stent reducing system and device |
US7243408B2 (en) | 2004-02-09 | 2007-07-17 | Boston Scientific Scimed, Inc. | Process method for attaching radio opaque markers to shape memory stent |
FR2867059B1 (fr) * | 2004-03-03 | 2006-05-26 | Braun Medical | Endoprothese a marqueurs pour conduit d'un corps vivant |
US6943964B1 (en) | 2004-06-01 | 2005-09-13 | Southeastern Univ. Research Assn. | Single element laser beam shaper |
US20050283226A1 (en) * | 2004-06-18 | 2005-12-22 | Scimed Life Systems, Inc. | Medical devices |
US7731890B2 (en) | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US7763066B2 (en) | 2004-07-28 | 2010-07-27 | Cook Incorporated | Stent with an end member having a lateral extension |
US8158904B2 (en) | 2004-08-13 | 2012-04-17 | Boston Scientific Scimed, Inc. | Method and apparatus for forming a feature in a workpiece by laser ablation with a laser beam having an adjustable intensity profile to redistribute the energy density impinging on the workpiece |
DE102004045994A1 (de) | 2004-09-22 | 2006-03-30 | Campus Gmbh & Co. Kg | Stent zur Implantation in oder um ein Hohlorgan mit Markerelementen aus einem röntgenopaken Material |
DE102004054084B4 (de) * | 2004-11-09 | 2007-08-02 | Admedes Schuessler Gmbh | Stent mit einem Marker zur Verbesserung der Röntgensichtbarkeit, die Verwendung sowie ein Verfahren zum Herstellen eines derartigen Stents |
US7508853B2 (en) | 2004-12-07 | 2009-03-24 | Imra, America, Inc. | Yb: and Nd: mode-locked oscillators and fiber systems incorporated in solid-state short pulse laser systems |
US9114033B2 (en) | 2005-01-10 | 2015-08-25 | Trireme Medical, Inc. | Stent with self-deployable portion |
US8002818B2 (en) | 2005-02-25 | 2011-08-23 | Abbott Laboratories Vascular Enterprises Limited | Modular vascular prosthesis having axially variable properties and improved flexibility and methods of use |
US20070038290A1 (en) * | 2005-08-15 | 2007-02-15 | Bin Huang | Fiber reinforced composite stents |
US7609218B2 (en) | 2005-10-12 | 2009-10-27 | The Directv Group, Inc. | Enhanced back assembly for Ka/Ku ODU |
US20070142903A1 (en) | 2005-12-15 | 2007-06-21 | Dave Vipul B | Laser cut intraluminal medical devices |
DE102005061932A1 (de) | 2005-12-23 | 2007-07-05 | Biedermann Motech Gmbh | Mehrwandiger Platzhalter |
US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
US20090076594A1 (en) | 2006-03-14 | 2009-03-19 | Patrick Sabaria | Method of monitoring positioning of polymer stents |
US20070266542A1 (en) | 2006-05-08 | 2007-11-22 | Cook Incorporated | Radiopaque marker for intraluminal medical device |
US20130325105A1 (en) | 2006-05-26 | 2013-12-05 | Abbott Cardiovascular Systems Inc. | Stents With Radiopaque Markers |
US20080009938A1 (en) | 2006-07-07 | 2008-01-10 | Bin Huang | Stent with a radiopaque marker and method for making the same |
US20080015684A1 (en) | 2006-07-11 | 2008-01-17 | Wu Patrick P | Method And Apparatus For Attaching Radiopaque Markers To A Stent |
US8460364B2 (en) | 2006-07-20 | 2013-06-11 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
WO2008011615A2 (en) | 2006-07-20 | 2008-01-24 | Orbusneich Medical, Inc. | Bioabsorbable polymeric composition for a medical device |
EP2043554A4 (de) | 2006-07-20 | 2012-07-25 | Orbusneich Medical Inc | Bioresorbierbare polymere medizinprodukte |
US20130150943A1 (en) | 2007-01-19 | 2013-06-13 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
US20080243226A1 (en) | 2007-03-30 | 2008-10-02 | Fernandez Jose E | Implantable stents with radiopaque markers and methods for manufacturing the same |
US8388673B2 (en) | 2008-05-02 | 2013-03-05 | Abbott Cardiovascular Systems Inc. | Polymeric stent |
US8303644B2 (en) | 2007-05-04 | 2012-11-06 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
US8002817B2 (en) | 2007-05-04 | 2011-08-23 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
EP2224861B1 (de) | 2007-10-17 | 2014-06-25 | ARO Medical ApS | Systeme und geräte zur torsionsstabilisierung |
US8057472B2 (en) | 2007-10-30 | 2011-11-15 | Ellipse Technologies, Inc. | Skeletal manipulation method |
US20090204203A1 (en) | 2008-02-07 | 2009-08-13 | Medtronic Vascular, Inc. | Bioabsorbable Stent Having a Radiopaque Marker |
US20110138022A1 (en) | 2008-08-12 | 2011-06-09 | Telefonaktiebolaget Lm Ericsson (Publ) | Fast Content Switching in a Communication System |
ES2686906T3 (es) | 2008-08-29 | 2018-10-22 | Smed-Ta/Td, Llc | Implante ortopédico |
CN102245132A (zh) | 2008-10-10 | 2011-11-16 | 奥巴斯尼茨医学公司 | 生物可吸收的聚合物医疗装置 |
US9186190B2 (en) | 2009-10-02 | 2015-11-17 | Drexel University | Functionalized nanodiamond reinforced biopolymers |
PT2752172T (pt) | 2010-01-30 | 2016-09-06 | Abbott Cardiovascular Systems Inc | Stents de polímero recuperáveis de esmagamento |
WO2011106387A2 (en) | 2010-02-23 | 2011-09-01 | University Of Connecticut | Natural polymer-based orthopedic fixation screw for bone repair and regeneration |
WO2011123203A1 (en) | 2010-03-29 | 2011-10-06 | Boston Scientific Scimed, Inc. | Flexible stent design |
US20110282428A1 (en) | 2010-05-13 | 2011-11-17 | Boston Scientific Scimed, Inc. | Biodegradable composite stent |
US8539663B2 (en) | 2010-08-23 | 2013-09-24 | Abbott Cardiovascular Systems Inc. | Reducing crimping damage to polymer scaffold |
JP2012074324A (ja) | 2010-09-30 | 2012-04-12 | Hitachi Ltd | 固体高分子形燃料電池 |
EP2438891A1 (de) | 2010-10-08 | 2012-04-11 | Biotronik AG | Stent mit erhöhter Sichtbarkeit im Röntgenbild |
US10166128B2 (en) | 2011-01-14 | 2019-01-01 | W. L. Gore & Associates. Inc. | Lattice |
US9199408B2 (en) | 2012-04-03 | 2015-12-01 | Abbott Cardiovascular Systems Inc. | Uniform crimping and deployment methods for polymer scaffold |
ES2692288T3 (es) | 2012-10-25 | 2018-12-03 | Arterial Remodeling Technologies S.A. | Marcador radiopaco para estents biorreabsorbibles |
US10292845B2 (en) | 2013-05-07 | 2019-05-21 | Kaneka Corporation | Stent, method for producing same and device for producing same |
US9337908B2 (en) | 2013-06-13 | 2016-05-10 | Nokia Technologies Oy | Space-time channel sounding in wireless network |
US9345597B2 (en) | 2013-07-09 | 2016-05-24 | Abbott Cardiovascular Systems Inc. | Polymeric stent with structural radiopaque marker |
US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
US9737368B2 (en) | 2015-02-24 | 2017-08-22 | Abbott Cardiovascular Systems Inc. | System and method for attaching a radiopaque marker bead to an endoprosthesis |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
-
2006
- 2006-01-04 US US11/325,973 patent/US20070156230A1/en not_active Abandoned
- 2006-12-21 PL PL14200352.4T patent/PL2910220T3/pl unknown
- 2006-12-21 WO PCT/US2006/049269 patent/WO2007081551A1/en active Application Filing
- 2006-12-21 DK DK14200352.4T patent/DK2910220T3/en active
- 2006-12-21 EP EP16177926.9A patent/EP3146941B1/de not_active Not-in-force
- 2006-12-21 SI SI200631774T patent/SI1973502T1/sl unknown
- 2006-12-21 ES ES14200352.4T patent/ES2586978T3/es active Active
- 2006-12-21 PT PT68481530T patent/PT1973502E/pt unknown
- 2006-12-21 PL PL06848153T patent/PL1973502T3/pl unknown
- 2006-12-21 JP JP2008549504A patent/JP5175220B2/ja active Active
- 2006-12-21 EP EP13161281.4A patent/EP2612620A3/de not_active Withdrawn
- 2006-12-21 DK DK06848153.0T patent/DK1973502T3/da active
- 2006-12-21 ES ES06848153.0T patent/ES2458191T3/es active Active
- 2006-12-21 EP EP14200352.4A patent/EP2910220B1/de not_active Not-in-force
- 2006-12-21 HU HUE14200352A patent/HUE029840T2/en unknown
- 2006-12-21 PT PT142003524T patent/PT2910220T/pt unknown
- 2006-12-21 LT LTEP14200352.4T patent/LT2910220T/lt unknown
- 2006-12-21 SI SI200731807A patent/SI2910220T1/sl unknown
- 2006-12-21 EP EP06848153.0A patent/EP1973502B1/de active Active
-
2014
- 2014-06-11 CY CY20141100429T patent/CY1115184T1/el unknown
- 2014-12-31 US US14/588,286 patent/US9532888B2/en active Active
-
2016
- 2016-02-18 HK HK16101845.7A patent/HK1213761A1/zh not_active IP Right Cessation
- 2016-10-10 CY CY20161101004T patent/CY1118086T1/el unknown
- 2016-11-21 US US15/357,987 patent/US10070975B2/en active Active
-
2018
- 2018-09-10 US US16/126,870 patent/US20190021809A1/en not_active Abandoned
Patent Citations (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321711A (en) * | 1978-10-18 | 1982-03-30 | Sumitomo Electric Industries, Ltd. | Vascular prosthesis |
US4902289A (en) * | 1982-04-19 | 1990-02-20 | Massachusetts Institute Of Technology | Multilayer bioreplaceable blood vessel prosthesis |
US4656083A (en) * | 1983-08-01 | 1987-04-07 | Washington Research Foundation | Plasma gas discharge treatment for improving the biocompatibility of biomaterials |
US5197977A (en) * | 1984-01-30 | 1993-03-30 | Meadox Medicals, Inc. | Drug delivery collagen-impregnated synthetic vascular graft |
US4633873A (en) * | 1984-04-26 | 1987-01-06 | American Cyanamid Company | Surgical repair mesh |
US4732152A (en) * | 1984-12-05 | 1988-03-22 | Medinvent S.A. | Device for implantation and a method of implantation in a vessel using such device |
US4718907A (en) * | 1985-06-20 | 1988-01-12 | Atrium Medical Corporation | Vascular prosthesis having fluorinated coating with varying F/C ratio |
US4818559A (en) * | 1985-08-08 | 1989-04-04 | Sumitomo Chemical Company, Limited | Method for producing endosseous implants |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4739762B1 (en) * | 1985-11-07 | 1998-10-27 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665B1 (en) * | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US4739762A (en) * | 1985-11-07 | 1988-04-26 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4740207A (en) * | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
US4723549A (en) * | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
US4722335A (en) * | 1986-10-20 | 1988-02-02 | Vilasi Joseph A | Expandable endotracheal tube |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4816339A (en) * | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US5306286A (en) * | 1987-06-25 | 1994-04-26 | Duke University | Absorbable stent |
US5192311A (en) * | 1988-04-25 | 1993-03-09 | Angeion Corporation | Medical implant and method of making |
US4994298A (en) * | 1988-06-07 | 1991-02-19 | Biogold Inc. | Method of making a biocompatible prosthesis |
US5502158A (en) * | 1988-08-08 | 1996-03-26 | Ecopol, Llc | Degradable polymer composition |
US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
US5289831A (en) * | 1989-03-09 | 1994-03-01 | Vance Products Incorporated | Surface-treated stent, catheter, cannula, and the like |
US5108755A (en) * | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
US5100429A (en) * | 1989-04-28 | 1992-03-31 | C. R. Bard, Inc. | Endovascular stent and delivery system |
US5084065A (en) * | 1989-07-10 | 1992-01-28 | Corvita Corporation | Reinforced graft assembly |
US5290271A (en) * | 1990-05-14 | 1994-03-01 | Jernberg Gary R | Surgical implant and method for controlled release of chemotherapeutic agents |
US5279594A (en) * | 1990-05-23 | 1994-01-18 | Jackson Richard R | Intubation devices with local anesthetic effect for medical use |
US5385580A (en) * | 1990-08-28 | 1995-01-31 | Meadox Medicals, Inc. | Self-supporting woven vascular graft |
US5607467A (en) * | 1990-09-14 | 1997-03-04 | Froix; Michael | Expandable polymeric stent with memory and delivery apparatus and method |
US5108417A (en) * | 1990-09-14 | 1992-04-28 | Interface Biomedical Laboratories Corp. | Anti-turbulent, anti-thrombogenic intravascular stent |
US5104410A (en) * | 1990-10-22 | 1992-04-14 | Intermedics Orthopedics, Inc | Surgical implant having multiple layers of sintered porous coating and method |
US5711763A (en) * | 1991-02-20 | 1998-01-27 | Tdk Corporation | Composite biological implant of a ceramic material in a metal substrate |
US5282860A (en) * | 1991-10-16 | 1994-02-01 | Olympus Optical Co., Ltd. | Stent tube for medical use |
US5593434A (en) * | 1992-01-31 | 1997-01-14 | Advanced Cardiovascular Systems, Inc. | Stent capable of attachment within a body lumen |
US5858746A (en) * | 1992-04-20 | 1999-01-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
US5306294A (en) * | 1992-08-05 | 1994-04-26 | Ultrasonic Sensing And Monitoring Systems, Inc. | Stent construction of rolled configuration |
US5383925A (en) * | 1992-09-14 | 1995-01-24 | Meadox Medicals, Inc. | Three-dimensional braided soft tissue prosthesis |
US5733925A (en) * | 1993-01-28 | 1998-03-31 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5733564A (en) * | 1993-04-14 | 1998-03-31 | Leiras Oy | Method of treating endo-osteal materials with a bisphosphonate solution |
US5618299A (en) * | 1993-04-23 | 1997-04-08 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5599301A (en) * | 1993-11-22 | 1997-02-04 | Advanced Cardiovascular Systems, Inc. | Motor control system for an automatic catheter inflation system |
US5725549A (en) * | 1994-03-11 | 1998-03-10 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5726297A (en) * | 1994-03-18 | 1998-03-10 | Lynx Therapeutics, Inc. | Oligodeoxyribonucleotide N3' P5' phosphoramidates |
US6169170B1 (en) * | 1994-03-18 | 2001-01-02 | Lynx Therapeutics, Inc. | Oligonucleotide N3′→N5′Phosphoramidate Duplexes |
US5591607A (en) * | 1994-03-18 | 1997-01-07 | Lynx Therapeutics, Inc. | Oligonucleotide N3→P5' phosphoramidates: triplex DNA formation |
US5599922A (en) * | 1994-03-18 | 1997-02-04 | Lynx Therapeutics, Inc. | Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties |
US5399666A (en) * | 1994-04-21 | 1995-03-21 | E. I. Du Pont De Nemours And Company | Easily degradable star-block copolymers |
US5874109A (en) * | 1994-07-27 | 1999-02-23 | The Trustees Of The University Of Pennsylvania | Incorporation of biological molecules into bioactive glasses |
US5593403A (en) * | 1994-09-14 | 1997-01-14 | Scimed Life Systems Inc. | Method for modifying a stent in an implanted site |
US5879713A (en) * | 1994-10-12 | 1999-03-09 | Focal, Inc. | Targeted delivery via biodegradable polymers |
US5707385A (en) * | 1994-11-16 | 1998-01-13 | Advanced Cardiovascular Systems, Inc. | Drug loaded elastic membrane and method for delivery |
US6171609B1 (en) * | 1995-02-15 | 2001-01-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5876743A (en) * | 1995-03-21 | 1999-03-02 | Den-Mat Corporation | Biocompatible adhesion in tissue repair |
US5605696A (en) * | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
US20020004101A1 (en) * | 1995-04-19 | 2002-01-10 | Schneider (Usa) Inc. | Drug coating with topcoat |
US5855612A (en) * | 1995-05-12 | 1999-01-05 | Ohta Inc. | Biocompatible titanium implant |
US5591199A (en) * | 1995-06-07 | 1997-01-07 | Porter; Christopher H. | Curable fiber composite stent and delivery system |
US5865814A (en) * | 1995-06-07 | 1999-02-02 | Medtronic, Inc. | Blood contacting medical device and method |
US5873904A (en) * | 1995-06-07 | 1999-02-23 | Cook Incorporated | Silver implantable medical device |
US5888533A (en) * | 1995-10-27 | 1999-03-30 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US5607442A (en) * | 1995-11-13 | 1997-03-04 | Isostent, Inc. | Stent with improved radiopacity and appearance characteristics |
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
US5733326A (en) * | 1996-05-28 | 1998-03-31 | Cordis Corporation | Composite material endoprosthesis |
US5874165A (en) * | 1996-06-03 | 1999-02-23 | Gore Enterprise Holdings, Inc. | Materials and method for the immobilization of bioactive species onto polymeric subtrates |
US5855618A (en) * | 1996-09-13 | 1999-01-05 | Meadox Medicals, Inc. | Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin |
US6676697B1 (en) * | 1996-09-19 | 2004-01-13 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5868781A (en) * | 1996-10-22 | 1999-02-09 | Scimed Life Systems, Inc. | Locking stent |
US5741881A (en) * | 1996-11-25 | 1998-04-21 | Meadox Medicals, Inc. | Process for preparing covalently bound-heparin containing polyurethane-peo-heparin coating compositions |
US5877263A (en) * | 1996-11-25 | 1999-03-02 | Meadox Medicals, Inc. | Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents |
US5728751A (en) * | 1996-11-25 | 1998-03-17 | Meadox Medicals, Inc. | Bonding bio-active materials to substrate surfaces |
US5733330A (en) * | 1997-01-13 | 1998-03-31 | Advanced Cardiovascular Systems, Inc. | Balloon-expandable, crush-resistant locking stent |
US5874101A (en) * | 1997-04-14 | 1999-02-23 | Usbiomaterials Corp. | Bioactive-gel compositions and methods |
US6042875A (en) * | 1997-04-30 | 2000-03-28 | Schneider (Usa) Inc. | Drug-releasing coatings for medical devices |
US5891192A (en) * | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
US20020004060A1 (en) * | 1997-07-18 | 2002-01-10 | Bernd Heublein | Metallic implant which is degradable in vivo |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6010445A (en) * | 1997-09-11 | 2000-01-04 | Implant Sciences Corporation | Radioactive medical device and process |
US6015541A (en) * | 1997-11-03 | 2000-01-18 | Micro Therapeutics, Inc. | Radioactive embolizing compositions |
US6022374A (en) * | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US6511748B1 (en) * | 1998-01-06 | 2003-01-28 | Aderans Research Institute, Inc. | Bioabsorbable fibers and reinforced composites produced therefrom |
US6709379B1 (en) * | 1998-11-02 | 2004-03-23 | Alcove Surfaces Gmbh | Implant with cavities containing therapeutic agents |
US6187045B1 (en) * | 1999-02-10 | 2001-02-13 | Thomas K. Fehring | Enhanced biocompatible implants and alloys |
US6183505B1 (en) * | 1999-03-11 | 2001-02-06 | Medtronic Ave, Inc. | Method of stent retention to a delivery catheter balloon-braided retainers |
US6177523B1 (en) * | 1999-07-14 | 2001-01-23 | Cardiotech International, Inc. | Functionalized polyurethanes |
US6706273B1 (en) * | 1999-08-14 | 2004-03-16 | Ivoclar Vivadent Ag | Composition for implantation into the human and animal body |
US6689375B1 (en) * | 1999-11-09 | 2004-02-10 | Coripharm Medizinprodukte Gmbh & Co. Kg | Resorbable bone implant material and method for producing the same |
US20020002399A1 (en) * | 1999-12-22 | 2002-01-03 | Huxel Shawn Thayer | Removable stent for body lumens |
US6537589B1 (en) * | 2000-04-03 | 2003-03-25 | Kyung Won Medical Co., Ltd. | Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material |
US6527801B1 (en) * | 2000-04-13 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Biodegradable drug delivery material for stent |
US6506437B1 (en) * | 2000-10-17 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device having depots formed in a surface thereof |
US6517888B1 (en) * | 2000-11-28 | 2003-02-11 | Scimed Life Systems, Inc. | Method for manufacturing a medical device having a coated portion by laser ablation |
US20030033001A1 (en) * | 2001-02-27 | 2003-02-13 | Keiji Igaki | Stent holding member and stent feeding system |
US6679980B1 (en) * | 2001-06-13 | 2004-01-20 | Advanced Cardiovascular Systems, Inc. | Apparatus for electropolishing a stent |
US6695920B1 (en) * | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
US6846323B2 (en) * | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US20050015138A1 (en) * | 2003-05-22 | 2005-01-20 | Andreas Schuessler | Stent made of a material with low radio-opaqueness |
US20050004653A1 (en) * | 2003-06-19 | 2005-01-06 | Scimed Life Systems, Inc. | Sandwiched radiopaque marker on covered stent |
Cited By (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100256744A1 (en) * | 1996-06-06 | 2010-10-07 | Jean-Claude Laborde | Bifurcation stent and method of positioning in a body lumen |
US9101501B2 (en) * | 1996-06-06 | 2015-08-11 | Biosensors International Group, Ltd. | Bifurcation stent and method of positioning in a body lumen |
US8845716B2 (en) * | 2005-01-17 | 2014-09-30 | Kyung Bum Lee | Multilayer-coated stent for controlled drug release and manufacturing method thereof |
US20060161242A1 (en) * | 2005-01-17 | 2006-07-20 | Lee Kyung B | Multilayer-coated stent for controlled drug release and manufacturing method thereof |
US9532888B2 (en) | 2006-01-04 | 2017-01-03 | Abbott Cardiovascular Systems Inc. | Stents with radiopaque markers |
US10070975B2 (en) | 2006-01-04 | 2018-09-11 | Abbott Cardiovascular Systems Inc. | Stents with radiopaque markers |
US20070266542A1 (en) * | 2006-05-08 | 2007-11-22 | Cook Incorporated | Radiopaque marker for intraluminal medical device |
US9358325B2 (en) | 2006-05-26 | 2016-06-07 | Abbott Cardiovascular Systems Inc. | Stents with radiopaque markers |
US8752268B2 (en) * | 2006-05-26 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Method of making stents with radiopaque markers |
US9694116B2 (en) | 2006-05-26 | 2017-07-04 | Abbott Cardiovascular Systems Inc. | Stents with radiopaque markers |
US8752267B2 (en) * | 2006-05-26 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Method of making stents with radiopaque markers |
US9038260B2 (en) | 2006-05-26 | 2015-05-26 | Abbott Cardiovascular Systems Inc. | Stent with radiopaque markers |
US20110034991A1 (en) * | 2006-08-07 | 2011-02-10 | Biotronik Vi Patent Ag | Endoprosthesis and method for producing same |
US20080243227A1 (en) * | 2007-03-30 | 2008-10-02 | Lorenzo Juan A | Radiopaque markers for implantable stents and methods for manufacturing the same |
US9693885B2 (en) | 2007-03-30 | 2017-07-04 | DePuy Synthes Products, Inc. | Radiopaque markers for implantable stents and methods for manufacturing the same |
US8545548B2 (en) * | 2007-03-30 | 2013-10-01 | DePuy Synthes Products, LLC | Radiopaque markers for implantable stents and methods for manufacturing the same |
US7810223B2 (en) | 2007-05-16 | 2010-10-12 | Boston Scientific Scimed, Inc. | Method of attaching radiopaque markers to intraluminal medical devices, and devices formed using the same |
US20080288046A1 (en) * | 2007-05-16 | 2008-11-20 | Boston Scientific Scimed, Inc. | Method of Attaching Radiopaque Markers to Intraluminal Medical Devices, and Devices Formed Using the Same |
US20080306581A1 (en) * | 2007-06-07 | 2008-12-11 | Medtronic Vascular, Inc. | Streamlined Stents |
US20090035351A1 (en) * | 2007-07-20 | 2009-02-05 | Medtronic Vascular, Inc. | Bioabsorbable Hypotubes for Intravascular Drug Delivery |
US8566254B2 (en) * | 2007-12-21 | 2013-10-22 | Jelli, Inc. | Social broadcasting user experience |
US9078045B2 (en) | 2007-12-21 | 2015-07-07 | Jelli, Inc. | Social broadcasting platform |
US20090187936A1 (en) * | 2007-12-21 | 2009-07-23 | Jelli, Inc. | Social broadcasting |
US8856814B2 (en) | 2007-12-21 | 2014-10-07 | Jelli, Inc. | Dynamic selection of advertising content in a social broadcast environment |
US9089422B2 (en) * | 2008-01-24 | 2015-07-28 | Medtronic, Inc. | Markers for prosthetic heart valves |
US20090204203A1 (en) * | 2008-02-07 | 2009-08-13 | Medtronic Vascular, Inc. | Bioabsorbable Stent Having a Radiopaque Marker |
US9827119B2 (en) | 2010-01-30 | 2017-11-28 | Abbott Cardiovascular Systems Inc. | Polymer scaffolds having a low crossing profile |
US9867728B2 (en) | 2010-01-30 | 2018-01-16 | Abbott Cardiovascular Systems Inc. | Method of making a stent |
EP2752173A1 (de) | 2010-01-30 | 2014-07-09 | Abbott Cardiovascular Systems, Inc. | Gegen Quetschung unempfindliche Polymerstents |
US9763818B2 (en) | 2010-01-30 | 2017-09-19 | Abbott Cardiovascular Systems Inc. | Method of crimping stent on catheter delivery assembly |
US11324614B2 (en) | 2010-01-30 | 2022-05-10 | Abbott Cardiovascular Systems Inc. | Balloon expanded polymer stent |
US9770351B2 (en) | 2010-01-30 | 2017-09-26 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US9198785B2 (en) | 2010-01-30 | 2015-12-01 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US10123894B2 (en) | 2010-01-30 | 2018-11-13 | Abbott Cardiovascular Systems Inc. | Method of crimping stent on catheter delivery assembly |
WO2011094621A1 (en) | 2010-01-30 | 2011-08-04 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
EP2752172A1 (de) | 2010-01-30 | 2014-07-09 | Abbott Cardiovascular Systems, Inc. | Gegen Quetschung unempfindliche Polymerstents |
EP3300701A1 (de) | 2010-01-30 | 2018-04-04 | Abbott Cardiovascular Systems Inc. | Verfahren zum crimpen von polymerstents |
US9907685B2 (en) | 2010-01-30 | 2018-03-06 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
WO2011140973A1 (zh) * | 2010-05-10 | 2011-11-17 | 上海微特生物技术有限公司 | 一种能使聚合物支架在x射线下清晰可见的显影标记 |
US9642730B2 (en) | 2010-09-23 | 2017-05-09 | Abbott Cardiovascular Systems Inc. | Processes for making crush recoverable polymer scaffolds |
WO2012145106A1 (en) | 2011-04-19 | 2012-10-26 | Abbott Cardiovascular Systems Inc. | Processes for making crush recoverable polymer scaffolds |
US10307274B2 (en) | 2011-07-29 | 2019-06-04 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
US20140172112A1 (en) * | 2011-08-16 | 2014-06-19 | Depuy (Ireland) | Attachment mechanism |
US9655750B2 (en) * | 2011-08-16 | 2017-05-23 | Depuy (Ireland) | Attachment mechanism |
WO2013135260A1 (de) * | 2012-03-16 | 2013-09-19 | Admedes Schuessler Gmbh | Körperimplantat mit markerelement |
US10034787B2 (en) | 2012-06-15 | 2018-07-31 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
US11013626B2 (en) | 2012-06-15 | 2021-05-25 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
US9233015B2 (en) | 2012-06-15 | 2016-01-12 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
US20140013574A1 (en) * | 2012-07-11 | 2014-01-16 | Intact Vascular, Inc. | Systems and methods for attaching radiopaque markers to a medical device |
US10004619B2 (en) | 2012-09-20 | 2018-06-26 | Dotter Intellectual Pte, Ltd. | Polymeric stent and methods of manufacturing the same |
US10010436B2 (en) | 2012-09-20 | 2018-07-03 | Dotter Intellectual Pte, Ltd. | Polymeric stent and methods of manufacturing the same |
US20140114434A1 (en) * | 2012-10-22 | 2014-04-24 | Orbusneich Medical, Inc. | Medical device for implantation into luminal structures |
US10058436B2 (en) * | 2012-10-25 | 2018-08-28 | Arterial Remodeling Technologies Sa | Radiopaque marker for bioresorbable stents |
US20150272751A1 (en) * | 2012-10-25 | 2015-10-01 | Arterial Remodeling Technologies, Sa | Radiopaque marker for bioresorbable stents |
US11452623B2 (en) | 2013-03-13 | 2022-09-27 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
US11529249B2 (en) | 2013-03-13 | 2022-12-20 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
CN105188617A (zh) * | 2013-05-07 | 2015-12-23 | 株式会社钟化 | 支架、其制造方法及制造装置 |
US10292845B2 (en) | 2013-05-07 | 2019-05-21 | Kaneka Corporation | Stent, method for producing same and device for producing same |
US9980835B2 (en) | 2013-10-22 | 2018-05-29 | Orbusneich Medical Inc. | Medical device for implantation into luminal structures incorporating corrugated structural elements |
US11278708B2 (en) | 2014-01-15 | 2022-03-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US10426645B2 (en) | 2014-02-26 | 2019-10-01 | Dotter Intellectual Pte. Ltd. | Polymeric stent and methods of manufacturing the same |
US9510961B2 (en) * | 2014-02-26 | 2016-12-06 | Suntech Co., Ltd. | Polymeric stent and methods of manufacturing the same |
US20150238335A1 (en) * | 2014-02-26 | 2015-08-27 | Suntech Co., Ltd. | Polymeric stent and methods of manufacturing the same |
US10206796B2 (en) | 2014-08-27 | 2019-02-19 | DePuy Synthes Products, Inc. | Multi-strand implant with enhanced radiopacity |
US10821010B2 (en) | 2014-08-27 | 2020-11-03 | DePuy Synthes Products, Inc. | Method of making a multi-strand implant with enhanced radiopacity |
US10279154B2 (en) | 2014-10-31 | 2019-05-07 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US10307576B2 (en) | 2014-10-31 | 2019-06-04 | Cerevasc, Llc | Systems and methods for deploying an implant in the vasculature |
US10765846B2 (en) | 2014-10-31 | 2020-09-08 | CereVasc, Inc. | Methods and systems for draining cerebrospinal fluid into the venous system |
US9999527B2 (en) * | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
WO2016130663A1 (en) | 2015-02-11 | 2016-08-18 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
CN107405432A (zh) * | 2015-02-11 | 2017-11-28 | 雅培心血管系统公司 | 具有不透射线标记物的支架结构 |
CN112370224A (zh) * | 2015-02-11 | 2021-02-19 | 雅培心血管系统公司 | 具有不透射线标记物的支架结构 |
US20160228267A1 (en) * | 2015-02-11 | 2016-08-11 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
WO2016137843A1 (en) * | 2015-02-24 | 2016-09-01 | Abbott Cardiovascular Systems Inc. | System and method for attaching a radiopaque marker bead to an endoprosthesis |
US9737368B2 (en) | 2015-02-24 | 2017-08-22 | Abbott Cardiovascular Systems Inc. | System and method for attaching a radiopaque marker bead to an endoprosthesis |
US11478370B2 (en) | 2015-06-12 | 2022-10-25 | Abbott Cardiovascular Systems Inc. | Scaffolds having a radiopaque marker and methods for attaching a marker to a scaffold |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
US10610387B2 (en) | 2015-06-12 | 2020-04-07 | Abbott Cardiovascular Systems Inc. | Scaffolds having a radiopaque marker and methods for attaching a marker to a scaffold |
CN107847329A (zh) * | 2015-06-12 | 2018-03-27 | 雅培心血管系统公司 | 具有不透射线标记物的支架结构和将标记物附接至支架结构的方法 |
WO2016201317A1 (en) | 2015-06-12 | 2016-12-15 | Abbott Cardiovascular Systems Inc. | Scaffolds having a radiopaque marker and methods for attaching a marker to a scaffold |
EP4134047A1 (de) | 2015-06-12 | 2023-02-15 | Abbott Cardiovascular Systems Inc. | Gerüste mit röntgendichtem marker |
WO2017066201A1 (en) | 2015-10-16 | 2017-04-20 | Abbott Cardiovascular Systems Inc. | Non-circular radiopaque markers and methods for attaching a marker to a scaffold |
US10758718B2 (en) | 2015-10-30 | 2020-09-01 | CereVasc, Inc. | Systems and methods for endovascularly accessing a subarachnoid space |
US10272230B2 (en) | 2015-10-30 | 2019-04-30 | Cerevasc, Llc | Systems and methods for treating hydrocephalus |
US11951270B2 (en) | 2015-10-30 | 2024-04-09 | Cerevasc, Llc | Systems and methods for endovascularly accessing a subarachnoid space |
US10307577B2 (en) | 2015-10-30 | 2019-06-04 | Cerevasc, Llc | Systems and methods for deploying an implant in the vasculature |
WO2017106557A1 (en) | 2015-12-17 | 2017-06-22 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds |
US9861507B2 (en) | 2015-12-17 | 2018-01-09 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having modified marker structure near distal end |
US9956099B2 (en) | 2015-12-17 | 2018-05-01 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having reduced crimp profile and carrying radiopaque markers |
US10143573B2 (en) | 2015-12-17 | 2018-12-04 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having flexible distal end |
US10821008B2 (en) | 2016-08-25 | 2020-11-03 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
US11129738B2 (en) | 2016-09-30 | 2021-09-28 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
US11690738B2 (en) | 2017-12-06 | 2023-07-04 | Biotyx Medical (Shenzhen) Co., Ltd. | Stent and preparation method therefor |
EP3721839A4 (de) * | 2017-12-06 | 2021-08-18 | Biotyx Medical (Shenzhen) Co., Ltd. | Stütze und herstellungsverfahren dafür |
US11850390B2 (en) | 2018-03-08 | 2023-12-26 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
US11013900B2 (en) | 2018-03-08 | 2021-05-25 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
US11090175B2 (en) | 2018-07-30 | 2021-08-17 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
US11497638B2 (en) | 2018-07-30 | 2022-11-15 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
US11357648B2 (en) | 2018-08-06 | 2022-06-14 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
US10893963B2 (en) | 2018-08-06 | 2021-01-19 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
USD926984S1 (en) | 2018-09-13 | 2021-08-03 | Allergan, Inc. | Tissue expansion device |
USD977647S1 (en) | 2018-09-13 | 2023-02-07 | Allergan, Inc. | Tissue expansion device |
USD896383S1 (en) | 2018-09-13 | 2020-09-15 | Allergan, Inc. | Tissue expansion device |
US11160630B2 (en) | 2018-09-13 | 2021-11-02 | Allergan, Inc. | Tissue expansion device |
US11039944B2 (en) | 2018-12-27 | 2021-06-22 | DePuy Synthes Products, Inc. | Braided stent system with one or more expansion rings |
Also Published As
Publication number | Publication date |
---|---|
EP2612620A2 (de) | 2013-07-10 |
EP2910220B1 (de) | 2016-07-13 |
EP2910220A1 (de) | 2015-08-26 |
SI1973502T1 (sl) | 2014-06-30 |
EP1973502A1 (de) | 2008-10-01 |
PL2910220T3 (pl) | 2016-11-30 |
US9532888B2 (en) | 2017-01-03 |
CY1115184T1 (el) | 2016-12-14 |
PL1973502T3 (pl) | 2014-09-30 |
US20190021809A1 (en) | 2019-01-24 |
ES2586978T3 (es) | 2016-10-19 |
EP3146941A1 (de) | 2017-03-29 |
HUE029840T2 (en) | 2017-04-28 |
PT2910220T (pt) | 2016-08-19 |
JP2009522050A (ja) | 2009-06-11 |
SI2910220T1 (sl) | 2016-10-28 |
HK1213761A1 (zh) | 2016-07-15 |
US20170071764A1 (en) | 2017-03-16 |
LT2910220T (lt) | 2016-09-12 |
PT1973502E (pt) | 2014-06-09 |
JP5175220B2 (ja) | 2013-04-03 |
EP2612620A3 (de) | 2014-07-02 |
US20150148891A1 (en) | 2015-05-28 |
US10070975B2 (en) | 2018-09-11 |
WO2007081551A1 (en) | 2007-07-19 |
CY1118086T1 (el) | 2017-06-28 |
ES2458191T3 (es) | 2014-04-30 |
EP1973502B1 (de) | 2014-04-09 |
EP3146941B1 (de) | 2019-10-30 |
DK1973502T3 (da) | 2014-05-12 |
DK2910220T3 (en) | 2016-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10070975B2 (en) | Stents with radiopaque markers | |
US9694116B2 (en) | Stents with radiopaque markers | |
US20080009938A1 (en) | Stent with a radiopaque marker and method for making the same | |
US8745842B2 (en) | Method for attaching radiopaque markers to a stent | |
US9101698B2 (en) | Bioabsorbable stent with radiopaque layer and method of fabrication |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ADVANCED CARDIOVASCULAR SYSTEMS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DUGAN, STEPHEN R.;ABBATE, ANTHONY J.;REEL/FRAME:017436/0468;SIGNING DATES FROM 20051219 TO 20060104 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |